Neuroimmune Signaling in the Hippocampus: Mechanisms of Risk and Resilience by Williamson, Lauren Leshen
Neuroimmune Signaling in the Hippocampus: Mechanisms of Risk and Resilience 
by 
Lauren Leshen Williamson 
Department of Psychology & Neuroscience 
Duke University 
 
Date: _______________________ 
Approved: 
 
___________________________ 
Staci D. Bilbo, Supervisor 
 
___________________________ 
Christina L. Williams 
 
___________________________ 
Henry Yin 
 
___________________________ 
Cagla Eroglu 
 
___________________________ 
William Parker 
 
Dissertation submitted in partial fulfillment of 
the requirements for the degree of Doctor 
of Philosophy in the Department of 
Psychology & Neuroscience in the Graduate School 
of Duke University 
2014 
  
 
 
 
  
ABSTRACT 
Neuroimmune Signaling in the Hippocampus: Mechanisms of Risk and Resilience 
by 
Lauren Leshen Williamson 
Department of Psychology & Neuroscience 
Duke University 
 
Date: _______________________ 
Approved: 
 
___________________________ 
Staci D. Bilbo, Supervisor 
 
___________________________ 
Christina L. Williams 
 
___________________________ 
Henry Yin 
 
___________________________ 
Cagla Eroglu 
 
___________________________ 
William Parker 
 
An abstract of a dissertation submitted in partial 
fulfillment of the requirements for the degree 
of Doctor of Philosophy in the Department of 
Psychology & Neuroscience in the Graduate School of 
Duke University 
2014 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by 
Lauren Leshen Williamson 
2014 
 iv 
Abstract 
The interactions between the brain and the immune system are extensive and 
each has a profound influence on the other. The hippocampus is a brain region that is 
strongly impacted by the immune system, especially considering its large population of 
microglia, the resident immune cells of the brain. Cytokines and chemokines, the 
signaling molecules from immune cells, signal within the central nervous system (CNS) 
as well, and they are critical in hippocampal function. The relationship between the 
immune system and the hippocampus may underlie its particular vulnerability to 
diseases and disorders of the nervous system and the periphery. Conversely, immune 
signaling within the hippocampus is affected by alterations in hippocampal resilience 
and flexibility, such that increased hippocampal plasticity reduces vulnerability to 
immune challenges. The balance between risk and resilience in the hippocampus is 
modulated by immune signaling, especially by microglia. 
The hippocampus is vulnerable to immune challenges, disease and injury, but it 
is simultaneously a region capable of profound plasticity and flexibility. The following 
dissertation experiments were designed to assess the roles of microglia and their 
signaling molecules, cytokines and chemokines, during normal hippocampal processes, 
such as learning and memory and response to immune challenge. The first set of 
experiments examined the effects of a neonatal bacterial infection in rats on 
hippocampal-dependent learning and memory as well as neuronal and microglial 
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signaling in adulthood. In the first experiment, neonatally infected rats have impaired 
memory during fear conditioning following an immune challenge in adulthood. The 
impairment is caused by the exaggerated expression of the pro-inflammatory cytokine, 
interleukin (IL)-1β, within the hippocampus during learning. Hippocampal microglia 
are the primary source of IL-1β and the microglia in neonatally infected rats are 
“primed” by the infection into adulthood. In the second experiment, neonatally infected 
rats are more accurate on a Morris Water maze task following minimal training in 
adulthood, but have significantly impaired memory for a reversal platform location. In 
addition to improved accuracy, they have lower neural activation as measured by Arc 
protein expression within the dentate gyrus (DG) of the hippocampus. The next set of 
experiments assessed the effects of increasing hippocampal plasticity on immune 
signaling within the hippocampus. Following 7 weeks of environmental enrichment 
(EE), enriched rats had an attenuated pro-inflammatory response within the 
hippocampus in response to an in vivo peripheral immune challenge. The reduced 
immune response was specific to a subset of cytokines and chemokines and occurred 
only within the hippocampus and not adjacent cortical regions. Enrichment increased 
glial antigen expression within the DG as well. In another group of enriched rats, an ex 
vivo stimulation of isolated hippocampal microglia from EE rats demonstrated that the 
reduced microglial reactivity observed in vivo requires influence of other neural cell 
types on microglia phenotype, such that microglia within the DG of EE rats are smaller 
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than controls. Taken together, these experiments define cellular and molecular 
mechanisms of hippocampal vulnerability and resilience as a function of interactions 
between the brain and the immune system. 
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1. Introduction  
The brain and the immune system are extensively interconnected and each 
cannot function without the other. Indeed, there is a growing body of evidence that 
molecules once thought to function exclusively within the peripheral immune system 
are required for many normal processes within the central nervous system (CNS). The 
hippocampus is critical for learning and memory, and its unusual structure and 
signaling properties are thought to underlie its important role in cognition. The 
hippocampus is incredibly plastic, especially as one of only two robust neurogenic 
regions in the mature brain. The hippocampus is also remarkably vulnerable to injury, 
insult, and CNS disorders, such as ischemia and Alzheimer’s disease. The experiments 
in this dissertation provide evidence that immune molecules in the CNS and 
neuroimmune communication directly connect the unique plasticity and vulnerability of 
the hippocampus. 
Microglia, the primary immunocompetent cells in the CNS, densely populate the 
hippocampal formation. They can receive inputs from neurotransmitters and hormones, 
but their most common signaling molecules, cytokines and chemokines, were first 
defined by their roles in the immune system. As recent studies have shown, cytokines 
and chemokines are important for many aspects of neural function, and without them, 
brain homeostasis and cognitive performance suffers. They have roles in learning and 
memory paradigms (e.g., interleukin-1β in fear conditioning), plasticity (e.g., 
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interleukin-6 in LTP maintenance) and neurogenesis (e.g., CXCL12 in GABA signaling 
with newborn neurons): all critical functions and traits of the hippocampus. There is 
increasing support for the notion that hippocampal function requires microglia and 
normal neuroimmune signaling, including data that I will describe here. 
1.1 The Hippocampus 
The hippocampus is a brain region that has been studied as an individual entity 
for decades. This unique region encompasses the divide between the developing and 
adult brains and shares important characteristics with both developmental time periods. 
Its pseudo-developmental phenotype throughout the lifespan plays a role in its unique 
capabilities for plasticity and flexibility. In examining hippocampal plasticity, much has 
been learned about the abilities of the adult brain to respond flexibly to both positive 
(e.g., learning tasks) and negative (e.g., insult) stimuli as well as general properties of 
neural communication. The hippocampus is known to be a critical neural substrate for 
many expressions of learning and memory and without it, many learning paradigms are 
impossible to perform. In sum, the hippocampus offers a unique, well-studied region for 
understanding brain function, development and plasticity. 
1.1.1 Anatomical Organization 
The neuroanatomy of the hippocampus is one source of its appeal as a subject of 
study (for comprehensive review, see 1). Its main neuronal cells – pyramidal and 
granule cells – are organized in clear layers and its inputs are well-characterized. It is a 
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cortical structure and like the neocortex, it has large pyramidal and granule cells that 
signal with and respond to glutamate and acetylcholine and smaller interneurons that 
are inhibitory. Nevertheless, the hippocampus is distinct from the neocortex in several 
important ways. First, the hippocampal formation has a distinct laminar structure and 
development compared to the six layer cortex. The subdivisions of the hippocampus are 
well-characterized and each has a distinct role in hippocampal function. Second, the 
hippocampus has primarily unidirectional inputs rather than the radial connectivity (or 
crosstalk) that occurs in the rest of the cortex. Third, the hippocampus (specifically the 
dentate gyrus (DG)) shows a steady level of neurogenesis throughout the lifespan 
whereas the cortex has limited, if any, generation of new neurons. While the 
hippocampus has been considered a simpler, more accessible version of the cortex by 
neuroscientists and neurobiologists of the past, the hippocampus has its own 
remarkable role in brain function that is separate and distinct from other cortical 
regions. 
The hippocampus receives an incredible number of processed sensory inputs 
from many neocortical regions. However, hippocampal signaling is primarily 
unidirectional, unlike the bidirectional communication commonly seen within and 
between cortical layers. Through the perforant path, neurons in layer II of the entorhinal 
cortex (EC) project into the DG. The three-layer DG contains primarily granule cells 
packed tightly together in two linear regions often called blades. These two blades meet 
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to form the V-shape characteristic of this region and the activation of granule cells in 
response to EC input is relatively sparse compared to the number of inputs received. 
The convergence of inputs into the DG and its sparse activation are thought to 
orthagonalize the inputs and to distinguish them from one another, a phenomenon 
termed “pattern separation” (2, 3). The DG then projects its axons, called mossy fibers, to 
the CA3 (cornu Ammonis 3) pyramidal cell layer and the population of activated cells in 
the CA3 is larger compared to the number of DG cells projecting to it. The CA3 along 
with the CA2 and CA1 regions are included in what is often referred to as the 
hippocampus proper. The strata of the hippocampus proper include the oriens, the 
pyramidale, the lucidum, the radiatum, the lacunosum and the molecular, each of which 
contains populations of pyramidal cells similar to the cortex or signaling axons from one 
region to another. The CA2 region is distinct from both CA3 and CA1, but its inputs are 
not well-characterized. Inputs to the CA3 originate mostly from the DG, but the 
heterogeneous population of CA3 pyramidal cells also has associational communication 
and receives inputs from the EC. From the CA3, the axons (known as Schaffer 
collaterals, so named for the neuroscientist who first discovered them) project to the 
CA1 region. The CA1 region also receives input from the entorhinal cortex, but 
primarily from layer III. This region is thought to organize its inputs in a linear fashion; 
a phenomenon sometimes termed “pattern completion” (4, 5). The CA1’s projections 
signal to the subiculum, which then projects to the EC, or directly to layer VI of the EC. 
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The “loop” structure of the hippocampus permits information to be orthogonally and 
linearly processed before returning to the neocortex. This particular flow of neuronal 
signaling with its limited redundancy positions the hippocampus in a distinct place in 
cortical function and may underlie both its critical role in learning and memory as well 
as its more vulnerable attributes during insults. 
1.1.2 Learning and Memory 
The hippocampus has numerous important roles in learning and memory. 
However, the region is best known for its well-characterized roles in two types of 
learning and memory that are considered unique to this structure – spatial memory, and 
incidental or episodic memory. Lesion studies, in vivo electrophysiology, and newer 
methods of measuring neuronal activation in the hippocampus have underscored the 
necessity of a functional hippocampus for successful performance on many behavioral 
paradigms testing these two types of memory (e.g., water maze test, contextual fear 
conditioning, inhibitory avoidance, etc.). The hippocampus is central to the brain’s 
interaction with the surrounding environment and using external cues to successfully 
navigate the world. 
Spatial learning paradigms require a functioning hippocampus. Within the CA1 
region, place cells respond to specific locations in an explored environment (6) and 
rodents are skilled at using environmental cues to reach goals in a variety of tasks. One 
of the best known paradigms for testing spatial learning and memory is the water maze 
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task, first developed by Richard Morris (7). The task consists of a round pool filled with 
opaque water in which an escape platform is submerged. During a spatial learning task 
with a fixed platform, rats must swim in the pool to locate the platform, which remains 
in a stable location. They are often given 5 to 10 trials per day over the course of several 
days to learn the location of the platform. This type of water maze task requires the use 
of distal cues (within the testing room, but outside the “maze” or pool) for acquisition of 
the platform location, and this type of learning requires the hippocampus (8). Many 
other behavioral tasks (e.g., Barnes maze, radial arm maze) test spatial learning and 
memory as well. Often the distinctions between these types of task are based on the 
goals presented to the rodents during their performances; some relieve stress, others 
provide appetitive encouragement, but they all require the hippocampus’s continual 
processing of the outside environment for success. 
Incidental episodic learning and memory occur passively and automatically in 
the hippocampus. The exposure to novelty, whether a new space or new object in the 
environment, is automatically encoded in the hippocampus for possible retrieval during 
a second exposure to the novel context or relevant cue. For instance, recent technology 
has allowed researchers to use immediate early genes (IEGs), whose mRNA transcript’s 
cellular kinetics are well-defined, to label the activation of cells in the hippocampus in a 
time-dependent manner, based on a rat’s exposure to an environment one or more times 
(9-11). Hippocampal neurons are automatically activated by exposure to a new 
 7 
environment, and monitoring their activation defines the roles of each hippocampal sub-
region (11, 12). 
One type of incidental learning is classical conditioning, a behavioral paradigm 
of one-trial learning that has well-defined underlying neural correlates. Classical 
conditioning is the learned association between a conditioned stimulus (CS; e.g., tone) 
and an unconditioned stimulus (US; e.g., shock). Contextual fear conditioning assesses 
the recognition of the context in which fear learning occurs. The context itself can be the 
singular CS or coupled with another more discrete CS (e.g., tone). For example, in one 
version of contextual fear conditioning, rats are placed in a novel environment (e.g., a 
conditioning apparatus comprised of a Plexiglas box with a house light) for 2 to 3 
minutes to experience the context. Then a discrete CS (e.g., 15s tone) occurs followed by 
an aversive US (e.g., 2s 1.5mA shock from a metal grid floor that is connected to a shock 
generator). The amygdala mediates the explicit association between the cue presentation 
(CS) and the US (13, 14). The hippocampus interacts with the amygdala to mediate the 
association between the context and the US, such that rats that experience an aversive 
US in a specific context will display fear behavior (e.g. “freezing” or immobility, 
piloerection, shallow breathing) when placed into the context a second time. Their fear 
behavior is elicited without a second exposure to the US (15). A greater number of 
exposures to the conditioning context prior to the US presentation increases both the 
likelihood and the duration of freezing behavior during the subsequent exposures to the 
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context (16-18). Hippocampal lesions can cause retrograde or anterograde deficits in 
context recognition, depending on the timing of their application (19-22). In sum, the 
hippocampus is critical for recognition of the surrounding environment and the cues 
within it that provide guidance and direction towards desired goals. Importantly, 
immune molecules have direct effects on the learning and memory capabilities of the 
hippocampus. 
1.2 CNS-Immune System Interactions 
The immune system and the brain have a bi-directional relationship that is often 
mediated by cytokines and chemokines. The dogma of CNS “immune privilege” is no 
longer accurate as the interactions between neurons, microglia and the immune system 
are increasingly well-defined (23-25). Sickness behaviors are an example of one such 
interaction in which a peripheral immune challenge modulates behavior via the brain. 
Sickness behaviors are characterized by lethargy, anorexia, and a reduction in social and 
sexual behaviors (26, 27). Sickness behaviors, such as reduced motivation for food or 
social interactions, can be elicited by cytokine administration in the periphery and 
within the CNS (28) and does not require exposure to a pathogen or peripheral immune 
challenge in the periphery to occur. Nevertheless, administration of a pathogen or a 
substance that activates the immune system in the periphery causes a dramatic increase 
in cytokine expression that signals to the brain through the vagus nerve, which increases 
its signaling to the brain after exposure to interleukin-1β (29). Vagotomy reduces the 
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effects of peripheral circulating cytokines on sickness behavior (30), and direct 
administration of cytokines or their antagonists into the brain alter sickness behavior (31, 
32). Peripheral immune activation can affect the brain through the humoral response as 
well, in which the complement system is the first responder (33). The complement 
cascade promotes phagocytosis and inflammatory responses, which can increase these 
signals in the brain during blood-brain barrier disruption (33). Sickness behavior, which 
alters a rat’s motivational state via increasing brain cytokine or complement levels 
indicates that much of the immune system’s signaling allows the brain to modulate 
behavior and assist the immune system in ridding the organism of pathogens. In a 
region like the hippocampus that is constantly incorporating new cells, rewiring and 
repairing neural connections, increased inflammation may disrupt or irreparably 
damage these processes. 
1.2.1 Cytokines and Chemokines: Signals of the Immune System 
Cytokines and chemokines (chemotactic cytokines) are small cell-signaling 
molecules whose functions have been primarily defined within the immune system, but 
also have an important role in the nervous system and the interactions between these 
two systems. The immune system is a diffuse mediator of homeostasis and host defense 
to environmental perturbations, and cytokines and chemokines maintain 
communication among the diverse cell types required for immunological function. In 
the nervous system, they are secreted by neurons and glial cells and are important for 
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both inflammatory cascades within the CNS as well as normal cognitive function, 
though the latter remains less defined. In the periphery, chemokines are critical 
signaling molecules for the recruitment of leukocytes to sites of insult or injury. 
Chemokines are highly expressed in disease states, including kidney disease (34), 
atherosclerosis (35), rheumatoid arthritis, HIV-1 infections and cancer (36). They are 
important for the normal development of immune cells as well, including T-cells (37), B-
cells (38, 39), and the survival and development of hematopoietic progenitors (40-42). 
The dysregulation of cytokines is linked to many diseases and inflammatory 
disorders (e.g., atherosclerosis (43) and rheumatoid arthritis (44, 45)). On the other hand, 
cytokines are critical for normal functions including skeletal development (46), 
upregulating myelopoiesis during inflammation (47) and hematopoiesis (48). Their 
importance in cell migration and differentiation in the periphery (46, 48) indicates 
overlapping mechanisms for their roles in these processes within the brain, directly 
connecting the central nervous and immune systems.  
1.2.2. Immune Signaling Molecules: Chemokines and Cytokines in 
Normal Brain Function 
1.2.2.1 Cytokines 
1.2.2.1.1 Interleukin-1β 
Cytokines are a large family of molecules that are best characterized for their 
roles in immunomodulation and inflammation. Interleukin (IL)-1β is a well-
characterized cytokine that is important for proinflammatory signaling in the CNS and 
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the periphery. IL-1β is one of the major signaling molecules that mediate sickness 
behaviors. It has been implicated in a wide variety of inflammatory disorders as well 
(e.g., rheumatoid arthritis (49) and type 2 diabetes (50)). The cytokine is also important 
for hematopoietic precursor development; it is secreted by these precursors and they are 
regulated through both autocrine and paracrine signaling (51). Its role in the normal 
development of peripheral immune cells may offer a clue to its critical role in normal 
hippocampal function as well. The hippocampus is constantly renewing its population 
of neurons, and IL-1β may influence the migration and eventual fate of NSCs in the 
perpetual turnover of DG cells.  
The role of IL-1β in normal hippocampal function is well characterized (for 
comprehensive review, see 52). IL-1β is critical in hippocampal-dependent fear 
conditioning and memory consolidation (53) as well as the maintenance of LTP (54). 
I.c.v. administration of IL-1β in rats after water maze training improves memory, while 
i.c.v. administration of IL-1 receptor antagonist (IL-1ra), a cytokine that antagonizes IL-
1β function, results in memory impairment on the same task (55). IL-1 receptor knockout 
mice have impaired learning in the water maze and fear conditioning and have 
disrupted LTP (56). During hippocampal-dependent learning, IL-1β mRNA is induced 
in the hippocampus in wild-type mice, but transgenic mice overexpressing IL-1β have 
impaired hippocampal-dependent memory in the water maze and during fear 
conditioning (57). As these data show, the expression of IL-1β is required for normal 
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brain function. Nevertheless, overexpression or reduced expression of this cytokine 
impairs normal hippocampal function, such that physiological levels are narrowly 
defined (58). Transplantation of NSCs into the hippocampus from mouse lines with 
altered IL-1β signaling, as shown in the following studies, alters LTP and hippocampal-
dependent memory impairments. Isolated mice with increased IL-1β expression show 
weight loss, hippocampal-specific impairment in both fear conditioning and water 
maze, and reduction of LTP; the impairments in the isolated mice are reversed by 
transplanting NSCs from IL-1 receptor antagonist transgenic overexpression mice (59). 
Blocking the effects of IL-1β with IL-1ra within the hippocampus alleviates the negative 
effects of overexpression of IL-1β following the stress of isolation. In IL-1 receptor KO 
mice, transplantation of NSCs from WT mice into the hippocampus reverses memory 
impairments in fear conditioning and water maze and restores LTP function in the 
hippocampus (60). Modulation of IL-1β signaling to appropriate physiological levels 
prevents or eliminates any deficits caused by under- or overexpression. As these data 
indicate, IL-1β has a significant role in hippocampal function as do other cytokines.  
1.2.2.1.2 Other Cytokines 
Many other cytokines play important roles in regulating peripheral immune 
function and inflammation. Their role as signaling molecules during an acute immune 
response provides another mechanism by which they may modulate neuronal signaling 
during normal brain function. Many of these cytokines have been characterized for their 
 13 
roles in modulating brain function in addition to their roles in the peripheral immune 
system. For instance, TNFα is a primary signal in neuronal cell death cascades (61) and 
increased TNFα is associated with Alzheimer’s disease, major depressive disorder and 
other disorders characterized by neuroinflammation. TNFα has never been implicated in 
short term or long term potentiation per se, but it has a critical role in synaptic scaling, 
the adjustment of synaptic strength based on alterations in network-wide electrical 
activity. LTP maintenance may require IL-6, though it is difficult to assess in neural 
tissue (62), and high frequency stimulation in the hippocampus increases IL-6 mRNA 
expression (63).  
LTP is strongly inhibited by interferon-γ (IFNγ) (64). IFNγ also impairs short 
term plasticity in the CA1 sub-region of rat hippocampal slices (64), and prevents 
dendritic, but not axonal, outgrowth from rat neonatal hippocampal neuron cultures 
and induces retractions of dendrite outgrowth (65). Application of IFNγ to rat 
hippocampal neuronal cultures during the peak of synaptogenesis reduces spontaneous 
excitatory post-synaptic currents (EPSCs) and increases spontaneous inhibitory PSCs 
several weeks later (66). Similar to IL-1β, other cytokines can disrupt neuronal 
communication when they are present in supra-physiological levels.  
Inflammation, characterized by overexpression of several cytokines, can impair 
neurogenesis or new cell survival in the hippocampus.  Endotoxin (e.g., 
lipopolysaccharide or LPS) injection (i.p.) increases neuroinflammation and inhibits 
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neurogenesis (67). LPS application to neuronal cultures causes a neuroinflammatory 
response that is reversed by addition of a non-steroidal anti-inflammatory drug 
(NSAID) to cultures of hippocampal NSCs. Indomethacin, an NSAID, increases 
neurogenesis in hippocampal cultures from irradiated adult rats and restores 
neurogenesis to control levels (67). Adult hippocampal neurogenesis is impaired by 
TNFα signaling mediated by TNF receptor 1 (TNF-R1) basally and following SE, while 
TNF-R2 does not (68). Proliferation of NSCs is increased by members of the IL-6 family, 
including LIF and ciliary neurotrophic factor (CNTF). Conversely, IL-6 itself negatively 
impacts the differentiation of NSCs (69). Curiously, peripheral immune activation in 
antigen-induced arthritis in mice transiently increases proliferation of NSCs in the 
hippocampus, such that increased inflammatory tone in the organism encourages 
neurogenesis (70).  While high levels of cytokines, such as IL-1β and TNFα, can disrupt 
neurogenesis or encourage aberrant neurogenesis (e.g., during seizure), there may also 
be a role for “alternatively activated” microglia as described above (71-73). For example, 
microglia stimulated by IL-4 or low levels of IFNγ in vitro promote neurogenesis (74). 
IFNγ applied directly to NSC cultures increases neural differentiation and neurite 
outgrowth, while TNFα does not (75). Microglial activation in culture can be shifted, and 
the distinct profiles of secreted cytokines that result from these shifts in phenotype have 
differential effects on the fates of NSCs (for reviews, see 76, 77). Taken together, these 
findings demonstrate an important role for cytokines beyond their well-characterized 
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role in neuroimmune pathologies. The neurogenic niche of the hippocampus relies on 
these immune molecules to maintain, encourage and, occasionally, inhibit neurogenesis.  
1.2.2.1.3 Chemokines 
Chemokines are a subset of cytokines (8-12 kD) that are important for chemotaxis 
of various cell types, including immune and neural cells. The receptors for these small 
proteins are G-protein-coupled receptors that have 7 transmembrane domains; the 
similarity between these receptors results in broad promiscuous binding of the 
chemokine ligands and a lack of specificity between various ligands and their potential 
receptors (78). The family of chemokines is large with over 40 ligands and a host of 
receptors that bind to them. In addition to their roles in immune function, increasing 
evidence demonstrates roles for chemokines in homeostasis in addition to their roles in 
pathology. 
Many chemokine ligands and receptors are important in normal brain function. 
For instance, CXCR2 expression in HEK cells increases both the apparent affinity of 
GluR1 homomers for glutamate and the GluR1 homomer channel open probability (79). 
Application of CXCL2, a ligand for CXCR2, on Purkinje neurons cultured from the 
cerebellum increases spontaneous AMPA-type glutamatergic excitatory activity (79). 
Fractalkine (CX3CL1) reduces AMPA-mediated currents in hippocampal neuron culture 
preparations, through the interaction of CX3CL1 with its receptor, CX3CR1 (80). 
Fractalkine also alters EPSCs evoked by electrical stimulation of Schaffer collaterals in 
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patch-clamped CA1 pyramidal neurons in the rat hippocampus (81). The same 
preparation reduces AMPA current responses through a Gi-coupled dependent 
attenuation of intracellular cAMP. In hippocampal development, CXCL12 (SDF-1), in 
concert with its receptor CXCR4, selectively modulates hippocampal neuron axon 
outgrowth without altering branching (82). CXCR4 modulates synaptic depression in 
the cerebellum (83). CXCL12 reduces NR2B subunit expression in NMDA receptors on 
cultured cortical neurons, and the reduction of this subunit decreases calcium 
excitotoxicity (84). CXCL12 is also directly involved in GABA-ergic transmission within 
the DG. The chemokine is stored in vesicles of DG basket cells and co-localized with 
GABA vesicles that synapse onto immature neurons that are integrated in the granule 
cell layer (85).  In transgenic mice that overexpress CCL2 (monocyte chemotactic 
protein-1; MCP-1), neuronal responsiveness (as measured by extracellular field 
potentials in hippocampal slices) was reduced compared to wild-type littermate 
controls. In the same transgenic mice, short term potentiation was enhanced compared 
to controls and LTP was not affected by chronic exposure to CCL2 (86). Bath application 
of CCL2 on hippocampal slices in another study increased ESPC occurrence and quantal 
content (87). Application of chronic CCL3 (macrophage inflammatory protein (MIP)-1α) 
on hippocampal slices increases intracellular Ca2+ levels as well as NMDA-evoked Ca2+ 
signaling and increased numbers of NMDA receptors on the hippocampal neurons (88). 
These findings indicate roles for chemokines within the CNS and especially the 
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hippocampus in addition to their well-known roles as inflammatory molecules. While it 
is likely that chemokines have a part in neural communication in other brain regions, the 
singular signaling of the hippocampus is modulated heavily by chemokines. Many of 
these findings were defined in vitro and provide a foundation for future in vivo 
characterization of many chemokines, particularly during learning and memory 
paradigms. Taken together, these data indicate important relationships between 
chemokines and neurotransmitter signaling, especially in the hippocampus, in the 
normal brain. 
In addition to involvement in neural transmission, chemokines are vital to the 
migration and development of neural stem cells (NSCs) in the dentate gyrus of the 
hippocampus (89, 90). Ischemic insults, seizures, or other inflammatory stimuli increase 
proliferation of NSCs in the DG (91, 92), but NSCs themselves basally express several 
chemokine receptors, including CXCR4, the receptor for CXCL12, and CXCR2 (90, 93, 
94) and are induced to migrate by CCL2 (95). Given the chemotactic roles for 
chemokines in the peripheral immune system, their similar effects as chemoattractant 
signals for NSCs highlight a potential evolutionary conservation of these molecules (96) 
as well as the importance of neuroimmune communication in the normal brain. NSCs 
can have their own anti-inflammatory effects, especially when transplanted for the 
treatment of diseases and disorders, such as ischemia and EAE (97-100). The importance 
of chemokines in maintaining normal neurogenesis provides evidence for the double-
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edge sword of the hippocampal pseudo-developmental state –dysfunction of chemokine 
signaling can lead to damaging inflammatory cascades, but chemokines, and immune 
molecules in general, are required for normal hippocampal processes. Microglia, the 
main source of these immune molecules in the brain, also modulate neurogenesis and 
other hippocampal phenomena. 
1.3 Microglia 
Microglia are critical for normal brain function, especially as the primary source 
of cytokines and chemokines in the CNS. Recent work has illuminated the varied and 
dynamic role of microglia in the CNS, such as release of glutamate and nitric oxide as 
well as immune signaling molecules (for comprehensive reviews, see 101, and 102). 
Microglia constantly survey their surrounding microenvironment with their processes 
and can rapidly respond to changes in the extracellular milieu (103, 104). Microglia can 
dynamically shift from one activation state to another, altering morphology and 
phenotype in reaction to CNS and peripheral events. Interestingly, microglia, as long-
lived cells in the CNS, have a “memory” for previous activation states. Microglia can be 
“primed” or sensitized by insult or injury, and these primed cells are more likely to 
overreact to a subsequent immune challenge. Primed microglia are also more reactive at 
baseline, indicating an altered reactive tone in the sensitized brain. 
In the healthy brain, microglia directly interact with new neurons to modulate 
neurogenesis; ramified microglia actively phagocytose apoptotic cells during the 
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generation of new neurons (105).  Microglia make direct contact with synapses and 
dendritic spines to manipulate synaptic remodeling (106, 107). They eliminate dying 
neurons and damaged presynaptic boutons as well as provide space into which new 
post-synaptic structures may expand when they insert new receptors during plasticity 
events (102, 106, 107). In addition to their direct interactions with neurons, microglia are 
thought to be the primary in vivo source of cytokines and chemokines (73, 108-112), both 
of which are critical families of molecules for maintaining normal brain function. 
1.4 Immune Signaling in the Vulnerable Hippocampus 
The hippocampus is uniquely sensitive to disruptions in the environment, 
especially those that activate the immune system, as seen in many CNS pathologies. 
These pathologies often have more damaging effects in the hippocampus compared to 
other brain regions. The unique structure of the hippocampus, its perpetual 
developmental state, and the role of immune signaling molecules in normal 
hippocampal function may exacerbate the region’s vulnerability to injury and 
inflammatory disorders, especially those disorders that originate in or directly affect the 
CNS. 
1.4.1. CNS Disorders 
Several pathologies specific to the CNS have more damaging effects in the 
hippocampus compared to other brain regions as well, including Alzheimer’s disease, 
seizures and ischemia. The effects of AD on memory processes and hippocampal 
 20 
function are well-characterized, and neuroinflammation and dysregulation of immune 
signaling within this region are often considered hallmarks of AD. In both the human 
and rodent literatures, AD patients and model organisms consistently show increased 
cytokine and chemokine levels as well as increased microglial activation and activity (IL-
1β and IL-2 in humans, (113); IL-1β in humans, (114), human TNF polymorphisms, (115); 
reactive microglia in human subjects, (116); TGFβ in mice, (117)). Seizures are another 
disorder that dramatically affects the hippocampus and its function. Immune challenges 
early in life increase susceptibility to seizures (118-120) and seizures, in turn, increase 
immune activation in the hippocampus, the thalamus and the neocortex (IL-1β in mice, 
(121); IL-1β in rats, (122, 123); CCL2 in mice, (124)). Ischemia and the subsequent 
reperfusion of blood flow to the brain is particularly damaging to the CA1 region of the 
hippocampus for several days following the insult (125-127). Ischemic events that 
disrupt blood flow to the CNS (including those caused by cardiac arrest and other 
blockages) set off a series of inflammatory events, including the activation of microglia 
and astrocytes that release a storm of cytokines and chemokines (128, 129). Microglia 
and peripheral macrophages flock to the site of infarction (130-132). Notably, ischemic 
insults, seizures or inflammatory stimuli markedly impact the proliferation, migration, 
differentiation and survival of neural stem cells (NSCs) in the DG (91, 92), suggesting an 
important role for interactions between immune signaling and NSCs in pathology. 
 21 
1.4.2. Modeling Risk: Neonatal Infection 
1.4.2.1. Effects on Learning and Memory 
The developing brain is incredibly plastic, but also vulnerable to perturbations in 
the organism and its environment (for a review of the role of the immune system and 
the developing brain, see 133). Examining the effects of prenatal and neonatal events on 
later life outcomes, a field of study known as “early life programming,” provides 
possible mechanisms for neurological dysfunction, obesity and other detrimental 
disorders (134). Early life programming underscores the sensitivity of the brain during 
development to a wide number of disturbances. A growing body of research suggests 
that immune activation during early life has lasting consequences for the immune 
system, the CNS, and the communication between these two systems (135).  Notably, 
adult hippocampal function is often especially vulnerable to disruption following 
immune challenges during critical periods of development (136-140).  For instance, 
maternal immune activation or neonatal immune challenge with a diverse number of 
pathogens and immune activators (e.g., polyriboinosinic-polyribocytidylic acid 
(poly(I:C)), Escherichia coli, lipopolysaccharide (LPS), human immunodeficiency virus 
(HIV)-1 and IL-6) similarly disrupts spatial learning in adult male rats, suggesting 
convergence of immune activation onto common plasticity mechanisms (141-146).  In 
our laboratory, neonatal Escherichia coli infection has enduring consequences on 
microglial function, neuroimmune interactions and hippocampal function. In this 
model, rat pups are injected subcutaneously on postnatal day 4 (P4) with phosphate-
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buffered saline (PBS/controls) or a non-lethal dose of live E. coli. Neonatal infection with 
E. coli results in increased IL-1β and CD11b (a microglial antigen) mRNA expression in 
rat pup hippocampus within 24HR, but the infection is resolved within 72HR (147). In 
adulthood, these rats are tested for cognitive deficits, using a modified fear conditioning 
paradigm known as context pre-exposure. Rats experience multiple brief exposures to 
the conditioning apparatus on the first day. No other stimuli (US or CS) occur during 
these exposures. The hallmark of the pre-exposure paradigm is the process of repeated 
exposure to the conditioning context without any other CS or US (15, 16). Forming a 
representation of the context independent of other discrete cues (e.g. tone or light) 
requires the hippocampus (20-22). Twenty-four hours later, rats are transported to the 
conditioning apparatus, where they immediately receive a 2s footshock (US), and are 
returned to their home cages. Fear behavior is assessed 24HR after the immediate shock. 
Neonatally infected rats display cognitive deficits in adulthood, but only if they receive 
an immune challenge of lipopolysaccharide (LPS; 25μg/kg) by intraperitoneal (i.p.) 
injection after learning (148).  Neonatally infected rats that receive LPS immediately 
following the final episode of context pre-exposure on day 1 have impaired memory for 
the context 24HR after the shock (48HR after the LPS injection) (148). Importantly, the 
effects of neonatal infection on adult cognition are specific to the hippocampus. Rats 
treated with E. coli on P4 are not different from controls on hippocampal-independent 
measures (e.g., freezing to a tone previously paired with shock) (149).  
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Peripheral immune challenges alter the expression of cytokines and chemokines 
in the brain (30-32, 108, 147, 148, 150-153). IL-1β is a cytokine that is critical for learning 
and memory, as described above, and is a potential molecular mechanism for the 
cognitive impairments observed in the neonatally infected rats. The memory 
impairment shown in neonatal E .coli-treated rats injected with LPS is blocked by intra-
cisterna magna injection (i.c.m.) of a caspase-1 inhibitor given prior the LPS injection and 
subsequent context exposure. Caspase-1 is an enzyme that cleaves the pro-form of IL-1β 
into its mature active form. Inhibiting caspase-1 prevents the cleavage and the secretion 
of mature IL-1β protein. Caspase-1 inhibition prior to fear conditioning and LPS 
administration prevents the hippocampal-dependent learning impairments, 
underscoring the importance of IL-1β in hippocampal-dependent learning. Inhibiting IL-
1β with i.c.m. injection and rescuing cognitive impairments demonstrates that an 
exaggerated level of IL-1β within the CNS in neonatally infected rats impairs cognition 
(147).  
IL-1β is necessary for normal learning and memory (56, 57, 154); therefore its 
overexpression during cognitive impairments was of particular interest. IL-1β is 
expressed by neurons, astrocytes and microglia within the CNS, and its source during 
the observed cognitive impairments in the neonatally infected rats could not be 
identified from RNA expression and protein concentration data in whole hippocampal 
tissue.  An exaggerated hippocampal IL-1β response to LPS causes impaired memory in 
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neonatally infected rats, even when the LPS challenge is given 24HR prior to learning 
(108). In this case, the changes in IL-1β levels must stem from enduring signal 
modulation by a group or groups of resident cells. Several CNS cell types could be the 
source of the exaggerated IL-1β; however, the long-lived population of microglia is the 
primary source of many cytokines and chemokines (58, 109-112, 155, 156) and important 
for normal brain function (102-104, 106). These microglial cells are reactive to, or 
“primed” by, previous immune experience and may be permanently altered by prior 
insult or injury. Thus, it is both possible and likely that the source of exaggerated IL-1β 
is microglial cells and my work, described subsequently, examines this possibility.  
1.4.2.2 Effects on the Neurogenic Niche of the Hippocampus 
The development of neurons in the sub-regions of the hippocampus is well-
characterized and highly stereotyped. Microglia, however, have a unique developmental 
trajectory compared to other resident CNS cell types. Microglia do not originate from 
the neuroepithelium during fetal brain development, but instead colonize the fetal brain 
from the embryonic yolk sac arising from primitive myeloid progenitors (133, 157-161). 
They continue their proliferation and development within the CNS into the neonatal 
period as well (162, 163). A recent study in our laboratory revealed changes in microglial 
morphology and number throughout ontogeny, from the fetal period to adulthood by 
labeling the cells with ionized calcium binding adaptor molecule (Iba)1, a constitutively 
expressed microglial antigen. In male rats, the fetal brain (E17), newborn brain (P0), and 
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neonatal brain (P4) have greater numbers of Iba1-positive amoeboid microglia and 
microglia with stout (short, round) processes within the hippocampus. While the 
morphology of microglia does not directly map onto activation states (73, 164), a 
population of microglia that consists of amoeboid and stout processed cells, rather than 
cells with longer thinner processes and smaller cell bodies, likely indicates a more 
reactive or “primed” population of microglia in the early development of the brain. 
Later in life, just prior to adolescence (P30) and in adulthood (P60), microglia are more 
ramified or “quiescent” with significantly fewer cells in the population showing 
amoeboid or short process morphologies. The distinct development and introduction of 
microglia into the CNS may underlie the enduring effects of neonatal infection. If 
microglia are potentially more reactive in the fetal and early neonate brain, they may be 
more susceptible to immune disruption. The hippocampus, and especially the dentate 
gyrus, is simultaneously developing during this period of microglial colonization, and 
immune challenges could be especially detrimental to hippocampal development. E. coli 
exposure affects the neurogenic niches of the hippocampus, such that neonatally 
infected rats have more activated hippocampal microglia and reduced proliferation of 
neurons and astrocytes in the hippocampus at P4 compared to controls. In adulthood, E. 
coli-treated rats have decreased neuronal proliferation and decreased undifferentiated 
cell proliferation compared to controls (165). The enduring changes in microglia occur in 
parallel to enduring changes in neurogenesis and, potentially, hippocampal plasticity. 
 26 
1.5 Resilience 
As the above sections have shown, neuroimmune interactions influence the 
susceptibility of the hippocampus to disruptive influences, as well as modulate its 
functioning in the normal brain. In turn, the hippocampus also has a remarkable 
capacity for repair and flexibility. This region has a well-documented capability for long-
term change following positive interventions (e.g., exercise, environmental enrichment), 
and that capability for plasticity contributes to its resilience.  As a neurogenic region, 
new cells are continuously added to the hippocampal network and the rate of NSC 
proliferation and integration in the DG can be modulated by these positive 
interventions, creating the potential for resilience in the face of future disruptions. 
1.5.1. Plasticity 
The hippocampus has been a critical structure for characterizing many of the 
neurobiological mechanisms that underlie neuronal signaling, function and plasticity 
(for historical overview, see 1). While the hippocampal formation is dramatically 
different from the adjacent neocortex, its accessibility and large uniform populations of 
neurons provide an exciting source for neurobiological discoveries. These findings 
indicate possible cellular and molecular mechanisms for learning and memory, such as 
plasticity at the neural network, single neuron or even synapse levels in the adult brain 
(e.g., long-term potentiation (LTP) or AMPA receptor trafficking) (166, 167). 
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1.5.1.1. Cellular Plasticity 
Long-term potentiation (LTP), a phenomenon that strengthens and prolongs 
connections between neurons, was first observed in early experiments that stimulated 
the perforant path from the EC to the DG in anesthetized rabbits (168) and, later, in rats 
(169). High frequency stimulation of this pathway increased excitatory responses from 
the granule cells of the DG for several minutes following the original stimulation. In the 
hippocampus, this phenomenon is thought to be mediated by calcium ion (Ca+2) 
signaling through N-methyl-D-aspartic acid (NMDA) receptors in the DG and the CA1 
(170, 171). The NR2 subunits of the NMDA receptor have been implicated in LTP (and 
long-term depression/LTD) (172, 173), but their complete role has yet to be fully 
characterized. Increasing intracellular Ca+2 levels through NMDA receptors leads to the 
phosphorylation of and trafficking of AMPA receptors to synapses. Altering AMPA 
receptor number changes the effects of glutamate on the post-synaptic neuron and is 
thought to underlie the strengthened connections observed during LTP (for review, see 
174). To maintain overall structural signaling integrity, there is evidence of a 
phenomenon called synaptic scaling in which the increase in synaptic strength is spread 
among all the cells in a network, such that the mean rate of activity is constant and 
individual cells are not disproportionately strengthened or weakened by LTP (175-177). 
Dendritic spines that contain AMPA and NMDA receptors are also thought to be formed 
de novo during the induction of LTP (178, 179). Taken together, these data demonstrate 
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that the study of signaling within the hippocampus provide a foundation for neuronal 
behavior throughout the brain as well as many possible mechanisms for the functions of 
the unique structure. 
1.5.1.2. Neurogenesis 
The plasticity of the hippocampus extends beyond changes on individual 
neurons to structural alterations as well. Long after the brain is fully developed, the DG 
of the hippocampus continues to produce and integrate new neurons. Indeed, the DG 
develops differently from other hippocampal sub-regions, which have their own distinct 
schedules. The pyramidal neurons of the CA1 and CA3 regions migrate along the 
ventricle after cell division. CA3 neurons, whose generation peaks on embryonic day 17 
(E17) in rats, are generated slightly earlier than CA1 cells, which peak on E18 and 19 
(180-182). The DG, on the other hand, begins its development at the same time as CA1 
and CA3, but the generation of cells in the DG extends into the neonatal period, and 
beyond, into adulthood. The majority of DG granule cells are born during the first few 
weeks of life after birth (183-185). Importantly, the generation of DG granule cells does 
not cease after the developmental period, but continues into adulthood, albeit at a 
reduced level. In addition to differentiating into granule cells, the neural stem cells in the 
subgranular zone (SGZ), a neurogenic cell layer between the granule cell layer and the 
hilus, can also become astrocytes in the constant turnover of the DG. The capability of 
the DG to produce and incorporate new cells throughout the lifespan maintains a state 
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of pseudo-development in the hippocampus. This state offers exciting potential for 
flexibility and plasticity in hippocampal function, but may contribute to the selective 
vulnerability of the hippocampus.  
In the adult rat, neurogenesis occurs at a remarkable rate in the DG. In early 
adulthood, rats produce thousands of new cells in the DG daily (186). Few of the new 
cells survive; however, once new cells differentiate into neurons, they are integrated into 
the blades of the DG and begin to extend processes and connections to receive inputs as 
well as extend axonal projections to the CA3 (187, 188). Fully mature adult-born granule 
cells are functionally and morphologically identical to granule cells born during 
development (189-191) and are thought to replace a population of dying cells from the 
developmental period (192).  New neurons in adulthood, like those cells in the 
developing brain, go through distinct morphological (for review, see 193) and excitatory 
stages. Once they are post-mitotic, these new neurons become excitable first by γ-
aminobutyric acid (GABA) and then, as they continue to mature, their excitatory inputs 
switch to glutamate (190, 191). The purpose of new neurons and their importance for 
hippocampal function continues to be debated (2, 189, 194-201) and will not be discussed 
in detail here. Regardless of their function, the consistent turnover of the granule cell 
population establishes a constantly changing signaling pathway in the hippocampus, 
especially as the flow of information often passes through the DG on its way to the rest 
 30 
of the structure. The dynamism of this structure may be the basis for its occasionally 
fragile hold on normal function and homeostasis. 
1.5.2. Modeling Resilience: Environmental Enrichment 
Manipulations that positively influence hippocampal function can have enduring 
effects, even if the manipulations are performed in adulthood. Environmental 
enrichment (EE) is a housing manipulation that increases physical and social stimuli and 
has been shown to have profound impacts on hippocampal plasticity and function (202, 
203) and on the rest of the brain (204-206). Hippocampal neurogenesis is increased by EE 
in aged mice, concomitant with decreased anxiety and improved water maze acquisition 
(207). Cell survival and neurogenesis in the hippocampus are upregulated specifically 
by running and EE in adult mice (208). Gliogenesis of both astrocytes and microglia is 
increased in cingulate, motor and visual cortical regions by exposure to a running wheel 
(209) and astrogliogenesis is upregulated in the dentate gyrus by running (210).  
Astrocyte morphology is altered in the DG by EE, such that astrocytes differentially 
extend their processes in parallel with neuronal axon fibers (211). EE increases the 
expression of hippocampal growth factors (e.g., nerve growth factor (NGF) and brain-
derived neurotrophic factor (BDNF)) (212). BDNF is required for EE-mediated 
hippocampal neurogenesis as shown in BDNF knockout mice (213). Glial-derived 
neurotrophic factor (GDNF) is selectively upregulated in the granule cell layer of the DG 
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and the CA1 of the hippocampus following EE (214). Growth factors are known to 
increase neurogenesis (215) and modulate synaptic plasticity (for review, see 216).  
EE is neuroprotective after insult or injury (e.g., ischemia (217) or seizures (210)). 
EE rescues cognitive deficits in mice with impaired IL-1β signaling (154). Environmental 
interventions can also improve outcomes in chronic inflammatory conditions. In a 
mouse model of AD, running wheel exercise increases clearance of soluble fibrillary Aβ, 
an especially cytotoxic form of Aβ protein, and decreases inflammatory cytokines (e.g., 
IL-1β, TNFα) (218). Following whole brain irradiation, growth factor expression, DG 
neurogenesis and cognitive deficits were rescued by voluntary wheel running, such that 
mice that ran after irradiation showed an attenuated reduction in neurogenic growth 
factors, new cells in the DG and cognitive impairments on the Barnes Maze compared to 
their sedentary counterparts (219). Absent any peripheral immune challenge, wheel 
running altered cytokine tone in the hippocampi of female mice, reducing TNFα 
expression and increasing IL-6 and IL-1ra expression (220). Taken together, these data 
demonstrate that EE is a methodologically simple modulation that augments 
hippocampal plasticity and that rescues damaged brains from insult or injury. However, 
the ability of EE to alter neuroimmune function in a potentially neuroprotective manner 
is relatively unexplored.  
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1.6 Summary 
The following dissertation experiments attempt to analyze the roles of microglia 
and immune signaling molecules in the seemingly distinct traits of vulnerability, or risk, 
and plasticity, or resilience. These experiments aim to elucidate the connections between 
risk and resilience and to demonstrate that they share many of the same molecular 
mechanisms related to immune signaling within the CNS.  
The first set of experiments uses a model of neonatal infection to increase the 
vulnerability of the hippocampus and to investigate the effects on immune signaling as 
well as neural signaling within the hippocampus during learning and memory.  
Previous work with this model has indicated that observed learning impairments in 
neonatally infected rats are related to signaling within the CNS and enduring, well into 
old age (147, 165, 221). Two hippocampal-dependent learning and memory paradigms – 
contextual fear conditioning and the Morris Water Maze task – are used to assess the 
effects of neonatal infection on learning. The fear conditioning experiments aim to 
elucidate the cellular and molecular basis for previously observed learning impairments 
in adulthood that result from neonatal infection, while the Morris Water Maze 
experiments aim to investigate the effects of neonatal infection on behaviorally 
complicated tasks and the resulting neural activation within the hippocampus. In sum, 
these experiments consider the long-term effects of a disruption in immune signaling 
that occurs early in life. 
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The second set of experiments was designed to analyze the effects of a positive 
intervention, environmental enrichment, on immune signaling within the hippocampus.  
Environmental enrichment has not been used prior to immune challenge before these 
studies and its effects as a preventative intervention are as yet unknown. In addition to 
effects on mRNA and protein expression within the hippocampus and nearby regions, 
these experiments explore the changes that occur specifically within microglia following 
enrichment. While the first set of experiments in this dissertation examine the effects of 
altered immune signaling within the CNS on hippocampal function, the second set of 
experiments addresses the effects of altering hippocampal plasticity on immune 
signaling within the CNS, as we hypothesize that these traits exist in balance within the 
hippocampus to maintain the region’s unique phenotype. 
Research for all experiments was conducted with the approval of the Duke 
University Institutional Animal Care and Use Committee and the treatment of animal 
subjects was in accordance with the ethical and human treatment standards of the 
National Institutes of Health (NIH) and the National Science Foundation (NSF).  
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2. Microglia and Memory: Modulation by Early-Life 
Infection 
2.1 Introduction 
Previous work, as discussed in detail above, demonstrated that neonatal bacterial 
infection in rats leads to marked HP-dependent memory deficits in adulthood. 
However, deficits are only observed if unmasked by a subsequent immune challenge 
(peripheral LPS) 24 h before learning or immediately after learning. These data suggest 
the infection induces a long-term change within the immune system that, upon 
activation with the “second hit,” LPS, acutely impacts the neural processes underlying 
memory (147, 148, 222, 223). Indeed, preventing the synthesis of brain IL-1β before the 
LPS challenge completely prevents the memory impairment in neonatally infected (NI) 
rats (147). 
Earlier experiments, however, did not identify the cellular source of IL-1β during 
normal learning or possible mechanisms by which this cytokine is enduringly altered by 
early-life infection. Microglia are the primary immune cells of the brain, are long-lived, 
and have been linked to neurodegenerative disorders like AD (224, 225). However, 
whether microglia and their inflammatory products are a cause or consequence of 
neural dysfunction remains subject to intense debate (225). In this experiment, we 
assessed microglia as a possible cellular source of IL-1β as well as potential changes in 
microglial reactivity as a result of neonatal infection. We demonstrate that CD11b+ 
enriched cells (microglia/macrophages) are functionally primed within the adult HP of 
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NI rats basally, and produce exaggerated IL-1β ex vivo. However, an exaggerated IL-1β 
response within the HP microglia of NI rats in vivo requires LPS before learning. 
Furthermore, preventing microglial activation during learning prevents memory 
impairment in NI rats, even if preceded by LPS. Together, these data directly implicate 
microglial-derived IL-1β in normal learning for the first time. Importantly, they suggest 
an individual’s risk or resilience to neuroinflammatory disorders may critically depend 
on their early life experience, which can modulate normal cognition- dependent 
cytokine activity within the brain long after the initial insult.  
2.2 Materials and Methods 
2.2.1 Animals 
Adult male and female Sprague Dawley rats (70 d) were obtained from Harlan 
and housed in same –sex pairs in individually ventilated, microisolator polypropylene 
cages, with ad libitum access to food and filtered water. The colony was maintained at 
22°C on a 12 h light/dark cycle (lights on at 7:00 A.M.). Following acclimation to 
laboratory conditions, males and females were paired into breeders. Sentinel animals 
were housed in the colony room and screened periodically for the presence of common 
rodent diseases; all screens were negative. All experiments were conducted with 
protocols approved by the Duke University Animal Care and Use Committee.  
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2.2.2 Neonatal manipulations 
2.2.2.1 Bacterial culture 
Escherichia coli culture (ATCC 15746; American Type Culture Collection) vial 
contents were hydrated and grown overnight in 30 ml of brain-heart infusion (BHI) 
(Difco) at 37°C. Cultures were aliquoted into 1 ml stock vials supplemented with 10% 
glycerol and frozen at –20°C. One day before injections, a stock culture was thawed and 
incubated overnight in 40 ml of BHI at 37°C. The number of bacteria in cultures was 
read using a microplate reader (Bio-Tek Instruments) and quantified by extrapolating 
from previously determined growth curves. Cultures were centrifuged for 15 min at 
4000 rpm, the supernatants were discarded, and the bacteria were re-suspended in the 
dose-appropriate volume of sterile Dulbecco’s PBS (Invitrogen).  
2.2.2.2 Injections 
Female breeders were visually examined daily for confirmation of pregnancy, 
and male breeders were removed from cages before the birth of pups [postnatal day 0 
(P0)]. Litters were culled on P4 to a maximum of 10 pups/litter, retaining 2 females and 
as many male pups as possible. Male pups were injected subcutaneously (30G needle) 
on P4 with either 0.1 X 106 colony forming units of live bacterial E. coli/gram suspended 
in 0.1 ml of PBS (“NI rats”), or 0.1 ml of PBS (“control rats”). This dose of E. coli results in 
sustained (~48-72 h) increased plasma cytokines (IL-1β, IL-6) and corticosterone, as well 
as specific increases in IL-1β mRNA and related genes (IL-1 type 1 receptor, caspase 1) 
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within the brain by 24 h after infection (147, 226). All pups were removed from the 
mother at the same time and placed into a clean cage with bedding, weighed and 
injected individually, and returned to the mother as a group. Elapsed time away from 
the mother was <5 min. All pups from a single litter received the same treatment due to 
concerns over possible cross-contamination from E. coli. All injections were given 
between 2:00 P.M. and 4:00 P.M. All male pups for adult analyses were weaned on P21 
and housed in sibling pairs; remaining female pups were killed. To control for litter 
effects, a maximum of two pups per litter across a minimum of three different litters 
were assigned to a single experimental group. All rats were tested as adults between 65 
and 90 d of age.  
2.2.3 Behavioral Procedures 
2.2.3.1 Contextual and auditory cue fear conditioning 
2.2.3.1.1 Apparatus 
The conditioning context consisted of one of two identical black Plexiglas boxes 
with open fronts [41.9 cm length (L) X 40.6 cm width (W) X 46.2 cm height (H)] to allow 
viewing of animals. The conditioning chambers [30.5 cm (L) X 26.7 cm (W) X 33 cm (H)], 
within each black box, are made of clear Plexiglas with metal side walls (Coulbourn 
Instruments). Each chamber has a ceiling-mounted infrared activity monitor connected 
to a PC. A phasic auditory cue (2976 Hz tone presented at 76 dB) is also mounted on a 
ceiling of each black box. A 2 s, 1.5 mA shock is delivered through a removable floor of 
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stainless-steel rods. Each rod is 0.5 cm in diameter, is spaced 1.75 cm center to center, 
and is wired to a shock generator and scrambler. The chamber was cleaned with 70% 
alcohol and then water before each animal. 
2.2.3.1.2 Procedure 
Rats were allowed to explore the chamber for 2 min before the onset of a 15 s 
tone, followed immediately by a 2 s footshock (1.5 mA). Immediately after the 
termination of the shock, rats were removed from the chamber. Rats were tested 1 or 72 
h later for contextual fear in the original conditioning chamber for 6 min. For assessment 
of auditory-cue fear (3 h after 72 h context test), testing occurred in a novel chamber with 
triangular Plexiglas walls. The rod floors were removed, and a 7 W, 120 V AC clear, red 
light bulb illuminated the chests. Freezing was again assessed for 6 min. The auditory 
conditioned stimulus (CS) was absent for the first 3 min (pre-CS) and present for the last 
3 min (CS period). Freezing represents rats’ dominant defensive fear response and is 
characterized by an immediate suppression of behavior accompanied by immobility, 
shallow breathing, and a variety of other autonomic changes, including an increase in 
heart rate and piloerection. Freezing in these experiments was defined as the absence of 
all visible movement, except for respiration. Scoring began 10 s after the animal was 
placed into the chamber.  
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2.2.3.2 Open field 
To assess overall activity levels in unmanipulated rats treated with water versus 
minocycline (MINO) (50 mg/kg 12 h prior plus 25 mg/kg 1 h prior via oral gavage), rats 
were placed into a novel open field [45.1 cm (W) X 40.0 cm (L) X 34.9 cm (H)] beginning 
1 h after the final dose, and scored for 10 min using automated tracking software 
(ANYmaze; Stoelting).  
2.2.4 Drugs 
LPS derived from E. coli (serotype 0111:B4; Sigma-Aldrich) was suspended in 
sterile saline and administered via intraperitoneal injection at a dose of 25 µg/kg and a 
volume of 1 ml/kg. This dose was selected based on our previous body of work (147-149, 
165, 221-223, 227, 228). Minocycline hydrochloride (Sigma-Aldrich) was dissolved in 
water to a dose of 50 or 25 mg/kg in a volume of 5 ml/kg and administered via oral 
gavage (=10 and 5 mg/ml, respectively) using animal feeding needles (Harvard 
Apparatus; catalog #52-4199). The average body weight of the adult rats was 400 g. Rats 
were acclimated to the procedure using water for 3 d before each experiment.  
2.2.5 Tissue collection 
Adult rats were deeply anesthetized with a ketamine/xylazine mixture and 
transcardially perfused with ice-cold saline for 2 min to clear brain vessels of blood and 
peripheral cells. Brains were extracted and immediately dissected into prefrontal cortex 
(PFC), HP, and adjacent parietal cortex (PCX), depending on experiment, on an ice-
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chilled plate. Each reach was cut in one half along the sagittal plane, and one-half 
regions to be used for mRNA and protein analysis were placed into separate RNase- and 
endotoxin-free microcentrifuge tubes and snap frozen in liquid nitrogen. Tissues were 
stored at –80°C until processing. Brain hemispheres collected for assessment of protein 
versus mRNA were alternated between animals and distributed equally across groups.  
2.2.6 IL-1β ELISA 
Brain tissue samples were sonicated in cold Iscove’s culture medium containing 
5% fetal calf serum and a mixture enzyme inhibitor (in mM: 100 amino-n-caproic acid, 10 
EDTA, 5 benzamidine-HCl, and 0.2 phenylmethylsulfonyl fluoride), and IL-1β was 
measured from the supernatant using a commercially available ELISA kit (R&D 
Systems). The detection limit for IL-1β was 5 pg/ml. To adjust for variability in tissue 
sample sizes, total protein concentrations were determined by Coomassie Brilliant Blue 
AG-250 protein assay (180). Cytokine data are expressed as pictograms per 100 µg of 
total protein. 
2.2.7 Real-time qPCR 
For whole tissues, total RNA was isolated based on the TRIzol method (229). 
Following RNA isolation and enrichment, samples were DNase-treated, and cDNA was 
synthesized using the reverse transcriptase kit from QIAGEN. Amplification of cDNA 
was performed using a QuantiFast SYBR Green PCR kit (QIAGEN) on a Mastercycler ep 
realplex (Eppendorf). cDNA (1.5 µg in 1 µl) was added to a reaction master mix (12 µl) 
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containing HotStarTaq Plus DNA Polymerase, QuantiFast Buffer, SYBR Green I, Passive 
reference dye, and gene-specific primers (500 nM each of forward and reverse primer). 
Threshold cycle (CT) (number of cycles to reach threshold of detection) was determined 
for each reaction, and relative gene expression was determined using the 2–∆∆Ct method 
(230, 231) as follows: (1) we normalized the cycle threshold (CT) of the target gene of 
interest (T) to that of the reference (housekeeping) gene (R), for both the test (A) and 
calibrator samples (B): ∆CT(A) = CT(T,A) – CT(R,A) and ∆CT(B) = CT(T,B) – CT(R,B). We defined the 
calibrator samples as that with the lowest (baseline) expression. (2) We normalized the 
∆CT of A to B: ∆∆CT = ∆CT(A) – ∆CT(B), and (3) we calculated the expression ratio: 2–∆∆Ct = 
normalized expression ratio.  
2.2.7.1 Primer specifications 
Primer pairs for CD200 and CD200R were purchased from QIAGEN. We 
designed primers for CD11b, glial fibrillary acidic protein (GFAP), IL-1β, CX3CL1, 
CX3CR1, GAPDH, and 18s: cDNA sequences were obtained from GenBank at the 
National Center for Biotechnology Information (NCBI) (www.ncbi.nlm.nih.gov) and 
designed using an online Oligo Analysis and Plotting Tool (QIAGEN), which were 
tested for sequence specificity using the basic local alignment search tool at NCBI. 
Primers were obtained from Sigma-Aldrich, and specificity was verified by melt curve 
analysis. We estimated the efficiency of each primer set based on serial dilution standard 
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curves. All primer sets were estimated as >90% efficient, and within 5% of each other. 
Primer sequences are displayed in Table 1.  
2.2.8 Microglial isolation 
Isolated HPs were sliced into small pieces using a sterile razor and transferred 
into a 2 ml sterile tube with 1 ml of HBSS (w/o) (Invitrogen), which was spun at 300 X g 
at room temperature for 2 min. HP tissue was then brought to a single-cell suspension 
using Miltenyi’s Neural Tissue Dissociation Kit (P) (Miltenyi Biotec) in MACS buffer 
(PBS containing 0.5% BSA and 2 mM EDTA, pH 7.2) for 15 min at 4°C. HP tissue was 
then washed with 5 ml of MACS buffer and centrifuged at 300 X g at 4°C for 10 min. The 
tissue was resuspended in 500 µl of MACS buffer and passed through a nylon filter on 
LD columns (Miltenyi Biotec) exposed to a strong magnetic field. The flow through 
(demyelinated HP cells) and subsequent washes were collected into a new 15 ml conical 
and centrifuged at 300 X g at 4°C for 10 min. The demyelinated HP cells were 
immediately taken for flow-cytometric analysis (see Figure 5) or further fractionated 
based on CD11b expression as follows.  
2.2.8.1 MACS enrichment of CD11b+ cells 
Cells were resuspended in 500 µl of MACS buffer, stained with 5 µl of PE-
conjugated mouse anti-rat CD11b/c (BD Biosciences Pharmingen) and incubated for 10 
min in the dark at 4°C. The cells were washed with 5 ml of MACS buffer and centrifuged 
at 300 X g at 4°C for 10 min. Cells were then incubated with anti-PE MicroBeads 
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(Miltenyi Biotec) at 4°C for 15 min. The suspension was washed with 5 ml of MACS 
buffer and centrifuged at 300 X g at 4°C for 10 min, and the supernatant was aspirated 
off. The cells were resuspended in 500 µl of MACS buffer and were passed through a 
nylon mesh filter onto magnetized LS columns (Miltenyi Biotec). The columns were 
washed with 4 ml of MACS buffer and the flow through either collected into a clean 15 
ml conical (as CD11b/c-negative fraction) or discarded. Magnetically labeled CD11b/c-
positive cells were flushed out of the columns twice with MACS buffer into a clean 15 ml 
conical. Magnetically enriched cell fractions were centrifuged at 300 X g at 4°C for 10 
min, followed by resuspension in 500 µl of PBS (Invitrogen) or Neuro Media (high-
glucose DMEM supplemented with 20% FBS and 5 µg/ml forskolin). Isolated CD11b+ 
and CD11b- cells were then taken for flow-cytometric analysis (see Figure 6a), 
immediately lysed for RT-PCR analysis (see Figure 7), or placed into culture as follows.  
2.2.8.2 Ex vivo LPS stimulation 
Isolated CD11b+ or CD11b- cells were suspended in high-glucose DMEM plus 
20% FBS and 5 µg/ml forskolin and plated in 96-well round-bottom plates at a density of 
2 X 105 cells/200 µl/well. Cells were incubated with LPS (10 ng/ml) or media alone for 4 h 
at 37°C, 5% CO2. For each condition, samples were run in duplicate. At the end of 
incubation, the plate was centrifuged at 1000 X g for 10 min at 4°C to pellet cells. For 
RNA isolation, medium was removed and cDNA synthesized using the SuperScript III 
CellsDirect cDNA synthesis system (Invitrogen), according to the manufacturer’s 
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instructions. Real-time qPCR was performed as described above, and the level of IL-1β 
mRNA was quantified relative to the housekeeping gene 18s.  
2.2.9 Fluorescence staining and flow cytometry 
Demyelinated or MACS-enriched HP cells were washed once in PBS 
supplemented with 0.5% BSA and 2 mM EDTA (MACS buffer), followed by 
centrifugation at 350 X g for 5 min. MACS buffer was removed by decanting or 
aspiration and the pellet dispersed with agitation. Cells were incubated with 5 µl of rat 
Fc receptor block (CD32; BD Biosciences Pharmingen) for 5 min at 4°C. Next, 100 µl of 
PE-conjugated mouse anti-rat CD11b/c (BD Biosciences Pharmingen), diluted 1:500 in 
MACS buffer, was added, and cells were incubated for 15 min at 4°C in the dark. 
Because CD11b/c labels all macrophages, CD11b+ in a control experiment were 
incubated in anti-CD11b/c-PE and anti-CD45-FITC (BD Biosciences Pharmingen) to 
determine the relative concentration of perivascular macrophages, which label as 
CD11b+ / CD45 high (232). Cells were washed in MACS buffer, spun down at 350 X g for 5 
min, and t hen fixed in 200 µl of 1.5% paraformaldehyde before analysis using a FACS 
Canto II flow cytometer (BD Biosciences) and FlowJo software (Tree Star). For each 
sample, 10,000 events were collected and doublets were excluded from the analysis 
based on properties of size (forward scatter height and area). 
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2.2.10 Data analysis and statistics 
Data were analyzed using SigmaStat statistical software. For significant F scores, 
Holm-Sidak post hoc comparisons were performed to further distinguish among groups, 
and all differences were considered statistically significant if p < 0.05. 
2.3 Results  
2.3.1 Learning increases IL-1β protein specifically within the 
hippocampus, and this increase is modulated by neonatal infection 
We have reported that systemic infection with E. coli on P4 leads to marked HP-
dependent memory impairment in adulthood, but only if these animals receive a low-
dose LPS challenge after learning. The impairment is causally linked to exaggerated 
CNS IL-1β production, as preventing IL-1β synthesis within the brain completely 
prevents the memory impairment (147). Peripheral cytokine levels do not differ between 
groups in response to LPS, suggesting the critical difference within the brain is not due 
to a differential signal from the periphery (147). Curiously, LPS 24 h prior to learning 
also impairs long-term contextual memory in NI but not control rats despite the fact that 
HP IL-1β is largely undetectable in both groups 24 h after an LPS injection alone (147, 
149). These data led us to test the hypothesis that learning itself induces IL-1β protein 
within the HP, which is differentially modulated in NI rats. To test this, rats treated with 
PBS or E. coli on P4 were injected intraperitoneally with saline (SAL) or LPS as adults, 
and fear conditioned 24 h later (n = 8/group) (Figure 1a). Rats were assessed for memory 
72 h after fear conditioning (Figure 1c). Figure 1B illustrates that freezing to the context 
 46 
did not differ by neonatal treatment group at the short-term (1 h) memory test. 
Interestingly, there was a main effect of injection (F(1, 31) = 1.27; p = 0.001). Post hoc tests 
revealed that freezing was significantly lowest in the NI plus adult LPS group. In 
contrast to contextual memory, which depends on the HP, freezing to the tone did not 
differ by neonatal group in LPS-injected rats at the 72 h test, either before the tone 
presentation (pre-CS) or during the tone (CS) (Figure 1d). As expected, freezing was 
significantly greater to the CS than during the pre-CS period in all rats (F(1, 31) = 61.6; p = 
0.001). 
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Figure 1: Learning increases IL-1β protein specifically within the 
hippocampus, and this increase is modulated by neonatal infection. a) Rats treated 
with PBS or E. coli on P4 were injected as adults with saline (SAL) or LPS, and fear 
conditioned 24 h later received Fear Conditioning, Shock only, or Context exposure 
only (n = 8/grp). Brains were collected 2 h later to assess IL-1β protein. b) Freezing to 
the context did not differ between groups at the 1 h test, although freezing was greater 
overall in LPS-injected rats (**p<0.05). c) At the 72 h test, freezing to the context was 
significantly lowest in NI rats treated with LPS 24 h prior (*p<0.001). d) Freezing to the 
tone cue (CS) in an altered environment was significantly greater than the pre-CS 
period, but there was no neonatal group difference (#p<0.001). e) IL-1β was 
exaggerated within the HP of NI rats following LPS (*p<0.02). Moreover, IL-1β was 
detectable only in HP following SAL injection (**p<0.001), and concentrations were 
highest overall in HP (#p<0.001). F, Neither Shock nor Context alone produced the 
same exaggerated response within the HP of NI plus LPS rats, and concentrations 
were undetectable 24 h after SAL. Error bars indicated SEM. 
In a second group of rats from each group, brains were collected 2 h after fear 
conditioning to assess whether learning induces IL-1β protein within the HP, and 
whether this is altered by neonatal infection (n = 8/group). Figure 1e illustrates that IL-1β 
protein is markedly exaggerated within the HP of NI rats that received LPS 24 h before 
Fear Conditioning [main effects of neonatal treatment (F(1, 31) = 6.24; p < 0.02) and adult 
injection (F(1, 31) = 6.21; p < 0.02)], but not within either cortical region (p > 0.05). In a 
second experiment, adult rats from each neonatal group were injected with either SAL 
or LPS 24 h before an immediate 2 s Footshock only, or to a 5 min Context exposure 
only. Notably, LPS before either Shock alone or Context alone did not similarly 
exaggerate IL-1β within the HP (p > 0.05 for both) (Figure 1f). Importantly, a saline 
injection 24 h before either Shock or Context did not yield detectable IL-1β protein 
within the HP, indicating that learning is necessary to elicit the production of IL-1β 
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within the HP [ANOVA on ranks for all saline-injected rats (H = 24.1, df = 2, p < 0.001; 
Conditioned > Shock and Context)]. Finally, we assessed whether observed increases in 
IL-1β in the saline before conditioned group differed by brain region; there was a 
significant main effect of region (F(1, 47) = 29; p < 0.001), with concentrations higher in HP 
than either PCX or PFC. Based on these data, we included only the HP of Fear 
Conditioned and Shock only groups for all further analyses. 
2.3.2 Microglial but not astroglial activation marker expression within 
the hippocampus reflects the pattern of IL-1β 
Microglia and resident macrophages are a major source of IL-1β within the brain. 
However, many other cell types, including astrocytes and neurons, can produce IL-1β 
within the brain (233). To determine whether microglia/macrophages are the source of 
IL-1β during non-pathological conditions, specifically during learning, we assessed 
expression levels of CD11b and GFAP, two activity-dependent surface antigens present 
on microglia/perivascular macrophages, and astrocytes, respectively, within the 
opposite hemisphere of hippocampi assessed for IL-1β in Figure 1. For CD11b, there 
were significant main effects of neonatal group (*E. coli > PBS) and injection (**LPS 
>SAL) (F(1, 31) = 6.1; p < 0.02, for each) after Fear Conditioning (Figure. 2a). In contrast, 
there were no significant effects of neonatal treatment on CD11b expression in rats that 
received LPS 24 h before Shock only (p > 0.05). However, there was a significant effect of 
LPS (F(1, 31) = 6.9; p < 0.01). For GFAP, there were no significant group differences in either 
Fear Conditioned or Shock only groups (p > 0.05, for both; Figure 2b). 
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Figure 2: Microglial activation within the HP is exaggerated in NI rats, but 
only in response to learning. Rats treated with PBS or E. coli were injected as adults 
with SAL or LPS, and 24 h later received Fear Conditioning or Shock only (n = 
8/group). Brains were collected 2 h later, and CD11b and GFAP were assessed. a) 
CD11b relative expression to GAPDH was increased by LPS (**p < 0.02) and 
exaggerated within the HP of NI rats (overall effect of E. coli, *p < 0.02). Shock alone 
did not produce the same exaggerated response within the HP of NI rats, although 
there was a significant effect of LPS (**p < 0.05). b) GFAP expression did not 
significantly differ among groups, either following Fear Conditioning or Shock alone 
(p > 0.05 for both). Error bars indicate SEM. 
2.3.3 NI rats exhibit decreased neuronal inhibition within the 
hippocampus during learning compared with controls 
Our preliminary data suggest that microglia are more reactive to LPS in NI rats. 
Microglial activity is modulated in part via direct contact with neurons and their 
surface-expressed and secreted products. For instance, CD200 interacts with CD200R on 
myeloid cells and CX3CL1 (fractalkine) can bind to its receptor (CX3CR1) on microglia 
(234, 235). We determined expression levels for each of these factors in the same HP 
tissues presented above in Figure 2. In the Fear Conditioned group, there was a 
significant effect of neonatal treatment on CD200 (F(1, 31) = 6.7; p = 0.01), with expression 
lowest overall in NI rats, and significant effects of neonatal treatment (F(1, 31) = 15; p < 
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0.001) and injection (F(1, 31) = 7.1; p < 0.02) on CD200R (Figure 3a). In the Shock only 
group, there was a significant effect of injection on both CD200 and its receptor (F(1, 31) = 
7.1; p < 0.02, for both; SAL > LPS), but no neonatal group difference (Figure 3b). Thus, the 
decreased neuronal inhibition in NI rats compared with controls depends on learning. In 
contrast, there were no significant differences in CX3CL1 in either the Fear Conditioned 
(Figure 3c) or Shock only (Figure 3d) group; however, there was a significant effect of 
neonatal treatment on its receptor CX3CR1 (F(1, 31) > 5, p < 0.04; PBS > E. coli, for both). 
 
Figure 3: NI rats exhibit decreased neuronal inhibition within the HP 
compared with controls. Rats treated with PBS or E. coli on P4 were injected as adults 
with SAL or LPS, and 24 h later received Fear Conditioning or Shock only 
(n=8/group). Brains were collected 2 h later, and target genes were assessed. a) CD200 
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and its receptor (CD200R) were reduced overall in NI rats compared with controls in 
the fear conditioned group (*p<0.01 for both), whereas only CD200R was significantly 
decreased by LPS (**p<0.03). b) There were no neonatal group differences CD200 or 
CD200R in the Shock only group; however, both genes were decreased by LPS 
(**p<0.02). c, d) Fractalkine receptor (CX3CR1) but not its ligand was reduced overall 
in NI rats in both Fear Conditioned and Shock only groups. (*p<0.05 for all, compared 
with PBS). Error bars indicate SEM.   
2.3.4 Hippocampal microglia from NI rats express greater levels of 
CD11b on a per-cell basis compared with controls 
We have demonstrated that microglia show a marked increase in CD11b mRNA 
within the HP in response to the peripheral infection on P4, and that this increase is both 
sustained into adulthood, and exaggerated in response to LPS in NI compared with 
control rats (147, 227). Moreover, the number of microglia does not differ within the 
adult HP as a consequence of neonatal infection (165). Rather, the morphology of the 
cells is altered – microglial cell volumes are larger with shorter, thicker processes in 
adult rats infected as neonates compared with controls (165). These combined data 
suggest that changes in the function of microglia, rather than changes in number, may 
underlie the increased reactivity observed in adult NI rats, consistent with glial 
sensitization or priming.  
To assess this directly, the HP was collected from adult rats in each neonatal 
condition. Before tissue harvest, rats were perfused with cold saline to eliminate 
infiltrating cells. Dissected hippocampi were brought to single-cell suspensions using 
Miltenyi’s Neural Dissociation Kit (P) (Miltenyi Biotec) followed by myelin depletion 
and staining with APC-conjugated CD11b. Expression was quantified using a FACS 
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Canto II flow cytometer (Beckman Coulter) and analyzed using FlowJo software (Tree 
Star) (Figure 4a). The mean fluorescence intensity (MFI) of CD11b expression on gated 
microglia (CD11b+) was significantly greater on a per-cell basis in NI (n = 10) compared 
with PBS (n = 9) rats (t(17) = 2.5; p = 0.02) (Figure 4b). Notably, the relative frequency of 
CD11b+ cells in our mixed cell population did not differ between groups. These data are 
pooled from five independent isolations of two animals per treatment group per day. In 
a separate experiment, myelin-depleted cells from rats in each neonatal treatment group 
were sorted into CD11b+ and CD11b- fractions using magnetic beads. A rightward shift 
can be seen in the population of CD11b+ cells from NI rats, indicating increased 
expression (vertical line is provided for comparison) (Figure 4c).  Notably, the increased 
surface expression of CD11b in E. coli rats in both preparations indicates the increase 
observed in Figure 4b is not altered by the MACS enrichment step. Moreover, both 
increases were independent of any adult challenge, suggesting that surface antigen 
expression of microglia may be permanently altered as a consequence of the neonatal 
infection. Finally, a subset of sorted CD11b+ cells were stained with APC-conjugated 
CD11b/c and CD45 (a marker highly expressed on infiltrating macrophages), which 
revealed a large, dense cluster of CD11bhigh/CD45low cells. In contrast, CD11bhigh cells that 
also stained brightly for CD45 accounted for only 4.2% of the population, indicating the 
perivascular macrophage population was quite small (Figure 4d). 
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Figure 4: NI rats exhibit increased surface antigen expression of CD11b on 
isolated HP microglia. a) Adult rat HP were microdissected following cold saline 
perfusion and brought to single-cell suspensions using Miltenyi’s Neural 
Dissociation Kit followed by myelin depletion. Myelin-depleted cells were stained 
with APC-conjugated CD11b and analyzed using flow cytometry. Representative 
presorted populations are shown as distinct peaks. An unstained control is overlaid 
for reference (shaded histogram). b) Myelin-depleted cells from rats in each neonatal 
treatment group were stained with APC-conjugated CD11b to assess expression on 
microglia independent of selection using magnetic beads, which could influence 
antigen expression. The bar graph shows greater average (±SEM) MFI for CD11b 
reactivity from NI (n=10) compared with PBS (n=9) rats (*p<0.05). c) Myelin-depleted 
cells from rats in each neonatal group were sorted into CD11b+ and CD11b- fractions 
using magnetic beads. Representative postsorted (MACS) populations are shown. 
Purity was consistently >93% CD11b+ and ~99% CD11b- for all samples. A rightward 
shift can be seen in the population of CD11b+ cells from NI rats, indicating increased 
expression (vertical line is provided for comparison). d) Sorted CD11b+ cells were 
stained with APC-conjugated CD11b/c and CD45 (a marker highly expressed on 
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infiltrating macrophages), which revealed a large, dense cluster of 
CD11bhigh/CD45lowcells. In contrast, CD11bhigh cells that also stained brightly for CD45 
accounted for only 4.2% of the population, indicating the perivascular macrophage 
population was minimal.   
2.3.5 Hippocampal microglia/macrophages from NI rats express 
greater IL-1β compared with controls 
Next, we determined whether microglia from NI rats express more IL-1β to an 
LPS challenge ex vivo compared with controls. First, the HP was removed from 
untreated adult rats and a single-cell suspension was obtained using myelin depletion as 
described above. Isolated HP cells were magnetically sorted into CD11b+ and CD11b- 
fractions. HP CD11b+ and CD11b- fractions were then cultured with and without LPS 
(10 ng/ml) for 4 h. Immediately following culture, cells were lysed and total RNA was 
isolated for qPCR of relative IL-1β gene expression. IL-1β was only detected in the 
CD11b+ fraction, and its expression was increased following LPS in our group of 
unmanipulated control rats (Figure 5a). Next, we repeated this experiment using 
CD11b+ cells isolated from adult rats in each neonatal treatment group (n = 6 per group). 
There was a significant effect of neonatal treatment (F(1,8) = 8.2; p = 0.02); IL-1β expression 
was significantly higher in NI rats, both in response to media and to LPS (Figure 5b). 
This increase did not require an in vivo LPS challenge, suggesting that priming is 
intrinsic to microglia in NI rats and does not require an acute interaction with other cell 
types. While the basal increase in IL-1β in the NI plus media group may be a 
consequence of the isolation procedure itself, microglia are regardless more reactive in 
NI rats.  
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Figure 5: Isolated HP microglia from NI rats express exaggerated IL-1β mRNA 
ex vivo. a) Microglia were rapidly isolated from the adult HP of rats using myelin 
depletion and CD11b+ selection as described above in Figure 4. HP CD11b+ and 
CD11b- fractions were cultured with and without LPS (10 ng/ml) for 4 h at 37°C. 
Immediately following culture, cells were lysed and total RNA isolated for RT-PCR. 
Relative IL-1β gene expression to GAPDH is shown, which is increased in response to 
LPS and undetectable in the CD11b- population (n=2/group). b) Microglia were 
isolated from the adult HP of rats from each neonatal treatment. CD11b+ cells from NI 
rats express greater relative expression of IL-1β with or without LPS stimulation ex 
vivo, compared with controls (*p=0.02). The bars represent the average (±SEM) relative 
expression values for two rat HPs (pooled) per treatment group per day run as three 
independent experiments (n=6/group). 
 
2.3.6 The exaggerated increase in IL-1β in vivo in NI rats is microglial 
derived and requires learning 
Our first experiment demonstrated that CD11b expression reflects the pattern of 
IL-1β protein within the HP (Figures 1, 2). Moreover, microglia from NI rats express 
exaggerated IL-1β ex vivo (Figure 5). However, exaggerated expression of both CD11b 
and IL-1β in vivo were only observed in conjunction with fear conditioning (Figures 1, 2). 
To determine whether microglia are the source of exaggerated microglia during 
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learning, we measured the expression of IL-1β from directly isolated CD11b+ cells 
following either Fear Conditioning or Shock alone. Adult rats from each neonatal 
treatment group were injected intraperitoneally with either saline or LPS 24 h before 
Fear Conditioning (n = 6-7/group) or Shock (n = 4-5/group), and brains were collected 1 h 
later following cold saline perfusion. The HP was extracted and microglia were isolated 
using myelin depletion and CD11b+ selection as described above. Cells were 
immediately lysed and total RNA was isolated for qPCR of relative IL-1β gene 
expression. Following fear conditioning, there were significant effects of group (F(1,26) = 
4.7; p = 0.041) and injection (F(1,26) = 6.1; p = 0.021) (Figure 6a), with expression highest in 
the NI plus LPS group. In contrast, there were no significant effects of neonatal 
treatment in the Shock only group (Figure 6b). In a separate control experiment, CD11b- 
cells were selected from the HP of rats in each neonatal treatment that received Fear 
Conditioning 1 h before killing as above (n = 2/group), to confirm that 
microglia/macrophages are the primary source of IL-1β in response to fear conditioning. 
Figure 6c illustrates that IL-1β mRNA was completely undetectable in the population of 
CD11b- cells, consistent with our previous in vitro findings (Figure 5b). Finally, to 
further characterize the CD11b- population, we assessed GFAP and CX3CL1 mRNA; 
both were highly expressed in CD11b- cells but not CD11b+ cells (Figure 6d), indicating 
the CD11b- population contained astrocytes and neurons, respectively, which were 
viable and responsive to LPS.  
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Figure 6: HP microglia isolated 1 h after behavioral experience express 
exaggerated IL-1β mRNA in NI rats compared with controls, but only following 
learning. Rats treated with PBS or E. coli on P4 were injected as adults with SAL or 
LPS, and received Fear Conditioning or Shock only 24 h later. Microglia were rapidly 
isolated 1 h later using myelin depletion and CD11b+ selection as described above in 
Figure 4. Isolated microglia were immediately lysed and total RNA isolated for RT-
PCR. Relative IL-1β gene expression to GAPDH is shown. a) IL-1β mRNA expression 
was higher overall in NI rats (*p=0.04) and higher in response to LPS in both groups 
(p=0.02) (n=6-7/group). b) There were no group differences 1 h following Shock alone 
(p>0.05; n=4-5/group). c) IL-1β mRNA was undetectable in CD11b- cells collected from 
a separate group of rats in each condition that also received fear conditioning 
(n=2/group). d) GFAP and fractalkine/CX3CL1 were robustly expressed in CD11b- 
cells, indicating this population contained astrocytes and neurons, and was viable and 
responsive to LPS. Error bars indicate SEM.  
2.3.7 Minocycline prevents the exaggerated hippocampal IL-1β 
response, and the memory impairment in adult rats infected as 
neonates 
Our final goal was to prevent the memory impairment in NI rats by 
pharmacologically inhibiting microglia. To do this, we used the microglial inhibitor 
MINO, which we administered via oral gavage to mimic the clinical route of 
administration and to avoid the visceral irritation that occurs following intraperitoneal 
injection (our unpublished observations). In our first experiment, rats from each 
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neonatal treatment group were injected with LPS as adults, and fear conditioned 24 h 
later (Figure 7a). Rats also received a loading dose of MINO (50 mg/kg) or its vehicle 
(water) in a volume of 5 ml/kg via oral gavage 12 h before LPS injection, and received a 
second dose (water or 25 mg/kg) 1 h before injection. This dosing regimen significantly 
decreases proinflammatory cytokine production by microglia (236). Contextual memory 
was assessed 72 h after conditioning in one-half of the animals in each group (n = 
10/group MINO treated, and n = 8/group water treated). In the remaining animals (n = 8-
10/group), brains were collected 2 h after fear conditioning to assess IL-1β protein within 
the HP. For freezing behavior, there was a significant group by drug interaction (F(1,35) = 
7.3; p = 0.01). Freezing was lower in NI plus water rats compared with all other groups (p 
< 0.03 for all), and MINO given before LPS completely reversed this (Figure 7b). For IL-
1β protein, there was a significant interaction as well (F(1,35) = 4.9; p = 0.034); NI rats had 
higher IL-1β concentrations than control when treated with water before LPS (p = 0.01), 
whereas MINO given before LPS prevented this increase (Figure 7d, left panel).  
In a second group of rats, we determined whether MINO given just before fear 
conditioning but after LPS would similarly restore memory in NI rats (Figure 7). With 
the paradigm, a normal inflammatory response to LPS was allowed to occur before 
MINO administration, allowing us to confirm our hypothesis that exaggerated 
microglial-derived IL-1β production at the time of learning is critical for the observed 
memory impairment. Thus, rats from each neonatal treatment were injected with LPS as 
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adults, and fear conditioned 24 h later as before. All rats also received MINO 12 h and 
again 1 h before fear conditioning (12 and 23 h after LPS injections). There were no 
significant differences among groups in percentage freezing to the context (Figure 7c), 
indicating that MINO before conditioning also prevented the memory impairment in NI 
rats, even in the face of prior LPS. For IL-1β protein, there was also no group difference 
(Figure 7d, right panel), indicating that MINO before fear conditioning prevented the 
exaggerated increase we had previously observed in NI plus water rats (left panel). 
 
Figure 7: Inhibiting microglia before LPS or before learning prevents the 
memory impairment and exaggerated IL-1β response in NI rats. a) Adult rats treated 
on P4 with PBS or E. coli were injected with LPS 24 h before fear conditioning. A 
subset of animals were killed 2 h later to assess HP IL-1β protein, and the remaining 
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animals were tested for memory at 72 h. b) Rats in each neonatal treatment group 
(n=10/group) received water or MINO 12 h and again 1 h before LPS in experimental 
paradigm illustrated in a. Freezing was significantly lowest in NI rats that received 
water before LPS (*p <0.03), but this decrease was prevented by MINO. c) A separate 
group of rats in each neonatal treatment group (n=10/group) received MINO 12 h and 
again 1 h before Fear Conditioning (FC), but after LPS the previous day. A SAL-
injected group was also included to ensure that MINO alone did not impair learning. 
There were no differences between groups. d) IL-1β protein was significantly highest 
in NI rats that received water before LPS (*p<0.03) (left-most bars), but this increase 
was prevented by MINO, administered either before LPS (center bars), or in a 
separate group, after LPS but before FC (right-most bars). Error bars indicate SEM. 
Because MINO can have sedative properties, we included a group of saline-
injected rats in the latter experiment to confirm that MINO itself does not impair 
learning; freezing levels were comparable with LPS-treated and water-gavaged rats in 
the previous experiment. Finally, we also assessed activity levels in a separate group of 
untreated adult rats (n = 5/group, water vs. MINO) using an open field. This test was 
performed 1 h after the second gavage, at the time that fear conditioning would 
normally occur. Consistent with the results for fear conditioning, MINO did not alter 
overall activity in the open field compared with water-treated controls (total activity 
counts, mean ± SEM: water, 1000 ± 230; MINO, 1090 ± 220; p > 0.05; data not shown).  
2.4 Discussion  
Bacterial infection early in life leads to marked HP-dependent long-term memory 
impairments in adulthood, but only when combined with a “second hit,” an LPS 
challenge before learning, consistent with our previous findings (149). The primary goal 
of this study was to determine the cellular source of HP IL-1β in NI rats, which we have 
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demonstrated is exaggerated in response to LPS and causally linked to the memory 
impairment (147). We sought to determine the mechanism by which long-term changes 
in immune reactivity within the brain can endure in response to an initial insult, 
potentially throughout life, and thereby lend insight into the environmental risk factors 
for neurodegenerative and inflammatory disorders that exhibit a broad spectrum of 
prevalence and severity that cannot be explained by genetics alone. 
We show for the first time that CD11b+ cells are the sole source of IL-1β in 
response to normal HP-dependent learning and that early-life events can significantly 
modulate learning-dependent cytokine activity within the HP via a specific, enduring 
effect on microglial function. As noted previously, our population of CD11b+ cells does 
not exclude resident perivascular macrophages; however, this population is quite small 
(~4%). The resident microglia are functionally primed within the HP as a consequence of 
the early-life infection; specifically, microglia from NI rats express greater CD11b on a 
per-cell basis and produce more IL-1β ex vivo compared with microglia from controls. 
Furthermore, blocking microglial activation with MINO prevents both the sensitized IL-
1β response and the cognitive impairment in NI rats. Importantly, the sensitized IL-1β 
response 24 h after LPS in NI rats in vivo requires a learning experience, as Footshock or 
Context exposure alone does not elicit the same exaggerated response. Moreover, IL-1β 
protein was completely undetectable within cortical regions of saline-injected rats that 
experienced fear conditioning, whereas concentrations were low but detectable in the 
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HP of all rats. Thus, the learning experience itself induced IL-1β expression in a HP-
restricted manner. Finally, preventing microglial activation during learning prevented 
the memory deficit in NI rats, even following an adult LPS challenge. 
There is a significant literature documenting the role of IL-1β in both normal 
memory and in memory disruption (52). Physiological levels of IL-1β are required for 
memory, whereas aberrant levels (either too low or two high) become detrimental and 
are strongly associated with disorders like AD. IL-1β mRNA increases as a consequence 
of learning (57, 237). Furthermore, IL-1 type 1 receptor expression in astrocytes is 
important for HP-dependent LTP and long-term memory (60). However, the source of 
IL-1β during learning has not been demonstrated, and neurons, astrocytes, and 
microglia, among other cells, are thought to produce IL-1β within the brain (233). We 
show that learning, but not Shock or Context exposure alone, induces IL-1β protein 
specifically within the HP, and that its expression is markedly exaggerated in NI rats 
given LPS 24 h before. Moreover, we replicated this pattern for mRNA in purified 
CD11b+ cells (Figure 6), whereas IL-1β mRNA was completely undetectable in the 
population of CD11b- cells, regardless of behavioral experience (Figures 5, 6). Together, 
we have demonstrated that microglia are primed as a consequence of neonatal infection 
and that this priming leads to aberrant production of IL-1β specifically during learning 
in adulthood. Importantly, these data suggest that the resident microglia of the HP are a 
necessary component of normal memory formation. 
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The vulnerability factors leading to cytokine dysregulation within a given 
individual are not well understood, as the majority of research on IL-1β and cognition 
has been conducted in genetic mouse models either entirely lacking IL-1 or its receptor, 
or with overexpression of its antagonist, IL-1ra (52). Similarly, glial function has often 
been explored in models of induced injury (e.g., stroke, trauma) in which the 
precipitating event is intrinsic to the model, creating questions about etiology that are 
difficult to answer. There is compelling evidence from the neurodegeneration and aging 
literatures that microglia become sensitized or primed following initial activation (by 
largely unknown factors), which contribute to neuronal dysfunction or death (238-241). 
Notably, primed glia do not constitutively overproduce proinflammatory mediators. 
However, the response by primed glia to a subsequent challenge (e.g., systemic 
infection) is significantly exaggerated, compared with resting/quiescent glia that receive 
the same challenge (239). This pattern of sensitization is similar to the phenotype we 
observe in our “two-hit” model. However, our data provide the first evidence to our 
knowledge that early-life experience can change microglial function within the brain 
well beyond the initial insult, perhaps for the remainder of the life span. Indeed, we 
have demonstrated that NI rats exhibit accelerated cognitive decline in middle age (16 
months), independent of acute immune challenge, a change that is linked to exaggerated 
aging-related glial sensitization (221). Thus, aging itself, and its impact on glial 
reactivity, acts as a “second hit” only in rats made vulnerable by neonatal infection. 
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Increasing evidence suggests a role for microglia in normal synaptic plasticity 
mechanisms within the adult brain, including dendritic spine remodeling and 
elimination (106, 242-244). These cells are active and dynamic even when “quiescent” 
(103) (e.g., they continually survey their microenvironments by extending and 
contracting processes into nearby synapses with a frequency that is activity dependent 
(107, 245)). They have receptors for multiple neurotransmitters, including those 
important for learning and memory (e.g., ATP, norepinephrine, glutamate) (246). The 
requirement of learning to observe the exaggerated IL-1β response in NI rats 24 h after 
LPS in vivo implies a neuronal-glial interaction. CD200 and CX3CL1 are both expressed 
by neurons within the brain and tonically inhibit microglia via CD200R and CX3CR1, 
respectively (234, 235). Notably, these inhibitory factors decrease during aging and in 
neurodegenerative disorders like AD, likely contributing to increased microglial 
reactivity (247-249). Mice deficient in fractalkine receptor, CX3CR1, exhibit enhanced 
Tau pathology within the HP that is dependent upon microglial-derived IL-1β (250). In 
our study, CX3CL1 did not differ by group, whereas its receptor was decreased basally 
in NI rats, implicating a change at the level of microglia. In contrast, CD200 and its 
receptor were both reduced basally in NI rats, but only following fear conditioning. 
These data suggest there may be a rapid chemokine role for CD200 in synaptic plasticity 
similar to that already described for CX3CL1, which plays a role in AMPA receptor 
function in active synapses (81), but this hypothesis remains to be explored. 
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The mechanism by which learning leads to microglial production of IL-1β within 
the HP also remains to be determined. One notable finding in this study was that MINO 
before FC did not impair memory, given that constitutive levels of IL-1β are considered 
vital for memory formation as discussed previously. However, MINO did not 
completely suppress IL-1β in either group of rats (Figure 7d). Thus, while the protein 
concentrations are low, they are detectable, in contrast to saline-injected rats that do not 
receive fear conditioning (Figure 1, Panels e and f). Therefore MINO-treated rats likely 
maintain a threshold amount of IL-1β needed for memory consolidation. If true, this 
suggests that MINO prevents the production of IL-1β in response to an inflammatory 
stimulus (LPS), but not in response to a learning-induced stimulus/signal, which may be 
neurotransmitter/hormone mediated. Finally, there is evidence that MINO increases 
rather than suppresses the release of IL-1α (251, 252), which has been implicated in LTP. 
Importantly, these potential mechanisms of memory formation in the face of MINO are 
not mutually exclusive and remain to be further explored. 
In closing, we demonstrate for the first time that CD11b+ cells are the primary 
source of IL-1β within the HP during normal learning. Minocycline is an imperfect 
microglial inhibitor with nonspecific anti-inflammatory properties. However, our 
pharmacological and behavioral experiments combined with the finding that IL-1β was 
produced exclusively in CD11b+ cells directly as a consequence of learning strongly 
point to a critical role of microglia in normal learning. Most importantly, we have 
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identified an early-life risk factor that alters the normal, activity-dependent “set point” 
of IL-1β via a specific, enduring impact on microglia. Microglia derive from primitive 
yolk sac macrophage precursors, which are of mesodermal origin and enter the 
neuroectoderm during embryogenesis, a founding colony of which proliferates to 
populate the entire developing parenchyma (160). Thus, early-life events may exert 
enduring impacts on the brain and behavior of organisms via an impact on the function 
of these resident, long-lived immune cells. The hypothesis that the early-life 
environment is especially critical in determining later risk for disorders like AD is 
supported clinically (253, 254). Furthermore, in young adult humans, there is significant 
variability in learning and memory impairments following low-dose endotoxin 
treatment that is inversely correlated to induced circulating cytokine levels (255). Our 
data provide valuable insight into the mechanisms underlying such variability and 
suggest the interesting possibility that changes in cognition following low-dose 
endotoxin challenge in young adults may serve as a novel biomarker for increased risk 
of later-life dementia. This possibility, as well as the role of microglia and their secreted 
molecules in normal synaptic plasticity mechanisms more generally, warrants further 
research. 
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3. Neonatal infection modulates behavioral flexibility and 
hippocampal activation on a Morris Water Maze task  
3.1 Introduction 
Spatial navigation is sensitive to disruptions in cytokine signaling within the 
hippocampus, as described above, in Morris Water Maze studies with transgenic and 
knockout mice (55-57, 59, 60). As the previous experiments (Chapter 2) demonstrated, 
neonatally infected rats have altered IL-1β signaling within the hippocampus as well as 
primed microglia that remain reactive into adulthood. In addition to memory 
impairments in fear conditioning in adulthood following neonatal infection (108, 147-
149), we have demonstrated that neonatally-infected male rats acquire a platform 
location more quickly than controls on a Morris Water Maze task in young adulthood. 
Aged male rats that were treated with E. coli on P4, however, have impaired memory for 
the platform location 24HR after testing (221). We have also demonstrated alterations at 
the cellular level in neonatally-infected rats. E. coli infection on P4 significantly reduced 
proliferation of neurons in the CA1 and CA3 sub-regions of P6 pups and reduced the 
maturation and integration of neurons in the CA1, CA3 and DG regions of P33 rats 
(165).  Nevertheless, our previous work has not examined the effects of E. coli infection 
on hippocampal neuronal networks. The persistent changes in neurogenesis following 
early-life infection may be indirect evidence that hippocampal circuitry is enduringly 
altered in these rats.  
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Neuronal activation during behavioral tasks can be measured in a variety of 
ways. Immediate early gene (IEG; e.g. Arc/Arg 3.1, Zif268, cFos) expression is a non-
invasive technique for measuring cellular activation in the brain. Protein expression of 
IEGs has a well-defined time course; thus, assessing protein expression at specific times 
following behavior reveals the populations of neurons that were activated during a 
given behavioral task (9, 256-260). The intracellular kinetics of activity-regulated 
cytoskeleton-associated (Arc) mRNA and protein are well-characterized (9, 261, 262) and 
extensive work on Arc at both the mRNA and protein levels demonstrates a significant 
role for its activity-dependent transcription and translation as a mechanism for synapse-
specific plasticity (for reviews, see 263, and 264). Inhibiting Arc protein expression 
impairs long-term potentiation (LTP) and memory consolidation (265). Thus, we 
characterized Arc protein in this study as both a time-sensitive readout of neuronal 
activation and a representation of possible plasticity during a learning and memory task.  
In light of the growing literature on enduring cognitive changes following 
perinatal infection or inflammation, this study examines the effects of bacterial infection 
on spatial learning and, indirectly, its underlying neural correlates.  We assessed the 
impact of neonatal E. coli infection on water maze acquisition and memory in adulthood, 
and measured Arc expression following the memory probe to examine hippocampal 
activation patterns in rats exposed to bacterial infection early in life, along with age-
matched controls. Based on the acquisition and memory behavior that we observed and 
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the potential for neonatal infection to alter many brain regions and not solely the 
hippocampus, we then examined reversal learning acquisition and memory on the water 
maze task to assess cognitive flexibility in our neonatally-infected rats. 
3.2 Materials and Methods 
Specific animal, apparatus and procedural details appear below in the General 
Methods section. 
3.2.1 Experiment 1 
The goal of this experiment was to test the effects of neonatal infection on a 
challenging paradigm of minimal training on the Morris Water maze (MWM) task in 
adulthood. We trained the rats with limited, minimal exposure to the apparatus and, 
thus, increased the difficulty of the task compared to training over a greater number of 
days or with more trials per day. We trained neonatally-infected and control rats for 3 
days, 6 trials per day, to assess memory for a platform location after training. On the 
third day, half of the trained animals (n=36) were tested on a memory probe trial 2HR 
following their final training trial. The other half of the group (n=36) was tested on the 
probe trial 48HR following their last training trial. One hour after their respective probe 
trials, rats were taken for euthanasia. In addition to the trained rats, we assessed the 
effect of a single experience in the MWM on Arc expression in the DG, compared to 
expression after repeated experiences during training and testing. These rats were given 
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a single 60s trial in the pool without a submerged platform. One hour after their single 
trial, rats were taken for euthanasia. 
3.2.2 Experiment 2 
Based on our findings in Experiment 1, we assessed memory performance 
following extended training on the MWM task, increasing both trials per day and 
number of days of training. Rats received 5 days of 10 trials per day during training. 
One hour after a 48HR probe trial (60s), rats were euthanized and brains were collected. 
We assessed a separate group of rats that was “yoked” by latency to the trained rats to 
examine the importance of learning on neuronal activation in the DG during a 
hippocampal-dependent task. Yoked rats were treatment- and latency-matched to rats 
from the Extensive Training group. All yoked trials were conducted without a 
submerged platform, allowing for a similar experience in the environment without the 
act of learning. One hour after a memory probe trial (60s trial 48HR after last training 
trial), rats were euthanized and brains were collected. 
3.2.3 Experiment 3 
We next assessed cognitive flexibility with a reversal task paradigm on the 
MWM. Once rats were trained to the first platform location (5 days X 10 trials per day, as 
in Experiment 2) and tested on memory probe trials, the platform was moved to another 
location in the opposite quadrant (SE) of the pool. Rats were trained for 3 days of 10 
trials per day on the new platform location until they reached criterion (less than 10s 
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average escape latency). They were tested 48HR after the last trial for memory for the 
reversal platform location. Rats were taken 1 hour after the 48HR probe trial for brain 
collection. The reversal task was assessed in 2 separate groups of rats (total n =16) and 
their data for acquisition, reversal and the 48HR probe trial for the reversal platform 
location were pooled. 
3.2.4 General Methods 
3.2.4.1 Animals 
Adult male and female Sprague-Dawley rats were obtained from Harlan 
(Indianapolis, IN) and were pair housed for breeding after a week of acclimation to the 
facility. Female breeders were visually examined daily for confirmation of pregnancy, 
and male breeders were removed from cages prior to the birth of pups (P0). All rats 
were housed in individually ventilated polypropylene cages with ad libitum access to 
food and filtered water. The colony was maintained at 22°C on a 12:12h light:dark cycle 
(lights on at 0700 h). Sentinel animals were housed in the colony room and screened 
periodically for the presence of common rodent diseases; all screens were negative. All 
experiments were conducted with protocols approved by the Duke University 
Institutional Animal Care and Use Committee. 
3.2.4.2 Neonatal Manipulations and Bacterial Cultures 
All litters were culled on P4 to a maximum of 10 pups/litter, retaining 2 female 
and as many male pups as possible. The females were retained to prevent single sex 
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litters, but all female pups were euthanized at weaning (P21). All litters were born 
within 1 week of each other, and all studies were limited to males, limiting the 
conclusions about the data to males alone. Escherichia coli culture (ATCC 15746; 
American Type Culture Collection, Manassas, VA) vial contents were hydrated and 
grown overnight in 30ml of brain-heart infusion (BHI; Difco Labs, Detroit, MI) at 37°C. 
Cultures were aliquoted into 1ml stock vials supplemented with 10% glycerol and 
frozen at -20°C. One day before injections, a stock culture was thawed and incubated 
overnight in 40ml of BHI at 37°C. The number of bacteria in cultures was read using a 
microplate reader (Bio-Tek Instruments Inc., Winooski, VT) and quantified by 
extrapolating from previously determined growth curves. Cultures were centrifuged for 
15 min at 4000rpm, the supernatants were discarded, and the bacteria were re-
suspended in the dose-appropriate volume of sterile Dulbecco’s PBS (Invitrogen Corp., 
Carlsbad, CA). Male pups were injected subcutaneously using a 30G needle on P4 with 
either 0.1 x 106 colony forming units (CFU) of live bacterial E. coli/g suspended in 0.1 ml 
PBS or 0.1 ml PBS. All pups were removed from the mother at the same time and placed 
into a clean cage with bedding, injected individually, and returned to the mother as a 
group. Elapsed time away from the mother was less than 5 min. All pups from a single 
litter received the same treatment due to concerns of possible cross-contamination from 
E. coli. All injections were given between 1300 and 1430h. To control for possible litter 
effects, a maximum of 2 pups per litter were assigned to a single experimental group. 
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Pups were weaned on P21 into sibling pairs and remained undisturbed until adulthood. 
In adulthood, all male rats were trained and tested between ages P60 and P90 on the 
behavioral task. 
3.2.4.3 Behavior 
3.2.4.3.1 Apparatus 
The water maze task consisted of a black circular pool approximately 1.8m in 
diameter and filled with room temperature water. A circular platform 15.5cm in 
diameter was submerged 2cm below the surface of the water in the center of one of the 
pool quadrants, and the water was clouded by black non-toxic water-based tempera 
paint to obscure the platform location. The pool was located in a well-lit room 
(approximately 5.8m x 2.6m in dimension) with salient extra-maze cues, such as a table 
with a computer, large black stripes adhered to two walls, shelving that contained large 
objects and the experimenter who sat in a chair near the computer.  
3.2.4.3.2 Water Maze Training and Testing 
For three days prior to behavioral testing, all rats were weighed and handled for 
approximately 60 seconds each per day. Testing was conducted over several days, 
depending on the training paradigm. On the first day, rats were habituated to the pool 
and the platform. On the following days, rats were trained for 6 to 10 trials per day to 
find the platform in the pool in a constant location (center of NW quadrant). On each 
training trial, the rat started at a random start location (N, S, E, W, SE, SW, NE) and was 
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allowed to swim until climbing onto the escape platform or until 60 s had elapsed, at 
which point it was guided to the platform. After 15 s on the platform, the rat was dried 
with a towel and placed in a holding cage for a 5-min inter-trial interval. After the final 
training day, rats were given a memory probe test either 2HR or 48HR after the final 
trial, depending on the paradigm. For the probe trial, the platform was removed from 
the pool and the rats swam for 60s. One hour after their respective probe trials, rats were 
taken for euthanasia. 
Memory probe tests are reported as difference scores, calculated by assessing the 
time spent in the Target quadrant (previously containing the platform) and subtracting 
the time spent in the quadrant with the next highest value.  If the rat spent more time in 
the Target quadrant than any other quadrant, the difference score is positive. If the rat 
spent more time in a quadrant other than the Target, the difference score is negative. 
Each group’s score is an average of all the difference scores from the rats in the 
treatment group. The difference score is a conservative measure of performance in the 
MWM test, as it requires animals to be both accurate and precise in their identification of 
the target quadrant. 
3.2.4.4 Tissue Harvest 
Rats were deeply anesthetized with ketamine-xylazine cocktail and 
transcardially perfused with 0.9% saline followed by 4% paraformaldehyde in 0.1M PBS. 
Brains were post-fixed for 24h in 4% paraformaldehyde in 0.1M PBS and cryoprotected 
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in 30% sucrose for at least 3 days and then quickly frozen in -30°C isopentane. 40-μm 
coronal sections were cut through the dorsal and ventral hippocampus in a -20°C 
cryostat using the atlas of Paxinos and Watson (266) as a guide. Sections were stored at 
4°C in cryoprotectant until immunohistochemistry was performed. 
3.2.4.5 Immunohistochemistry 
3.2.4.5.1 Fluorescence Staining 
In Experiment 1, we examined Arc protein expression in one series of brain slices 
and NeuN (neuronal nuclei) protein in another series double-labeled with a cell 
proliferation marker not assessed here. Free-floating sections were first rinsed for 3x5 
min in 0.01M phosphate buffered saline (PBS) and also rinsed before each subsequent 
step, except between the blocking and primary antibody steps. Next, sections were 
washed in 50% methanol for 30 min. Sections were then blocked for another 30 min in 
5% normal goat serum and 0.3% Triton-X to block and permeabilize, respectively, in PBS 
(blocking buffer). Sections were then incubated overnight at room temperature in Arc 
primary antibody (1:1000, rabbit polyclonal, Wako Pure Chemical Industries, Ltd., 
Osaka, Japan) or NeuN primary antibody (1:500, mouse monoclonal, Chemicon 
International, Temecula, CA USA) in blocking buffer. The following day, sections were 
incubated for 2 h at room temperature in a solution of goat anti-rabbit antibody bound 
to AlexaFluor 568 (Arc) or goat anti-mouse antibody bound to AlexaFluor 488 (NeuN) 
(both 1:200, Invitrogen, Grand Island, NY, USA) in blocking buffer. After PBS washes, 
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sections were mounted on gel-coated slides and coverslipped with Vectashield (Vector 
Laboratories, Burlingame, CA). Coverslips were adhered to the slides using nail polish.  
3.2.4.5.2 Diaminobenzidine (DAB) Staining 
In Experiments 2 and 3, we did not perform double-label staining. Thus, we 
performed immunohistochemistry with a chromogen appropriate for a light microscope 
(DAB) for all subsequent experiments.  Free-floating sections were first rinsed for 3x5 
min in 0.01M phosphate buffered saline (PBS) and also rinsed before each subsequent 
step, except between the blocking and primary antibody steps. Next, sections were 
washed in 50% methanol for 30 min. Sections were then quenched in 0.6% hydrogen 
peroxide for 30 min and then blocked for another 30 min in 5% normal goat serum and 
0.3% Triton-X to block and permeabilize, respectively, in PBS (blocking buffer). Sections 
were then incubated overnight at room temperature in Arc primary antibody (1:1000, 
rabbit polyclonal, Wako Pure Chemical Industries, Ltd., Osaka, Japan) in blocking 
buffer. The following day, sections were incubated for 2 h at room temperature in a 
solution of biotinylated goat anti-rabbit secondary antibody (1:200, Vector Laboratories, 
Burlingame, CA USA) in blocking buffer. The Avidin-Biotin Complex (ABC) method 
was used to bind a complex of streptavidin-biotin peroxidase to the secondary antibody 
(1 h incubation), which was then developed with diaminobenzidine (DAB, Vector 
Laboratories, Burlingame, CA, USA) for 15-45 min to produce a colorimetric stain. 
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Sections were mounted on gel-coated slides, dehydrated and coverslipped with 
Permount.  
3.2.4.6 Cell Quantification 
Fluorescent images were visualized using a Zeiss 510 Metaseries inverted laser 
scanning confocal microscope (representative images shown in Figure 8a and 8b). Slices 
were continuously scanned from top to bottom (approximately 20μm) exhaustively at 
40X through the DG and at two sites (250μm x 250μm) in the CA1 to count Arc-positive 
cells. Five sections were counted for each rat and each section was at least 200 
micrometers from the previously counted section. The counts from each individual 
section were combined to create a single Arc-positive cell count value per rat.   
DAB-developed images were visualized with a light microscope (representative 
images shown in Figure 8c and 8d). Quantification of Arc-positive cells in the granule 
cell layer of the dentate gyrus in the hippocampus was performed using a Nikon Eclipse 
80i microscope on a Dell PC running StereoInvestigator software (MBF Bioscience, Inc., 
Williston, VT, USA). The boundaries of the dentate gyrus were traced using this 
software at a magnification of 10X and Arc-positive cells in the region of interest were 
counted at 40X. Five sections were counted for each rat and each section was at least 200 
micrometers from the previously counted section. The counts from each individual 
section were combined to create a single Arc-positive cell count value per rat.   
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Figure 8: Representative images from immunohistochemical staining. Each 
image shows the dentate gyrus in one hemisphere at 10X magnification. The scale 
bars indicate 100μm and the arrows indicate representative Arc+ cells. a) DG from a 
minimally trained control rat after the 48HR probe. b) DG from a minimally trained 
neonatally-infected rat after the 48HR probe. c) DG from an extensively trained 
control rats after the 48HR probe. d) DG from an extensively trained neonatally-
infected rat after the 48HR probe. 
3.2.4.7 Statistical Analyses 
Behavioral training was analyzed with a repeated-measures two-way ANOVA to 
analyze latencies in the water maze between treatment groups over several days of 
training. Memory probe tests and cell counts were analyzed with t-tests, comparing PBS 
and E. coli groups. F and t values for each analysis are reported in the Results section.   
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3.3 Results 
3.3.1 Experiment 1 
3.3.1.1 Neonatal treatment did not affect platform acquisition on the MWM during 
minimal training. However, neonatally-infected rats performed better than controls 
during a 48HR memory test. 
Minimal training on the MWM tested the effects of neonatal infection on a 
challenging spatial navigation task. Both neonatally-infected and control rats acquired 
the platform location during minimal MWM training at the same rate and improved 
over days of training (F(1,76)=91.3, p<0.001) (Figure 9a). Both groups performed equally 
well at the 2HR memory probe test (t(38)= −1.28, p=0.207) (data not shown), but 
neonatally-infected rats had significantly better memory at the 48HR probe (t(30)= −4.83, 
p=0.026) (Figure 9b).  
 
Figure 9: Neonatally-infected rats have better memory and decreased neuronal 
activation in the DG following minimal training. a) Both groups of adult rats (PBS- 
vs. E. coli-treated on P4) acquired the platform location on the water maze task 
equally well with minimal training (F(1,76 )= 9.13, p<0.001). b) Neonatally-infected rats 
had significantly better performance on the memory probe at 48HR (t(30) = -4.83, 
p=0.026). c) Arc protein in the DG of neonatally-infected rats was significantly lower 
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at the 48HR probe than in PBS-treated control rats (t(29)=2.47, p=0.020). There were no 
differences in Arc protein expression in the CA1 (not shown). d) After a single trial 
(SWIM), both treatment groups had equal Arc expression in the DG (t(25) = -0.32, 
p=0.75) and greater average expression compared to trained rats. 
3.3.1.2 Neonatally-infected rats had significantly less Arc activation in the DG during 
the 48HR probe following minimal training. 
During the 48HR memory probe test after minimal training, neonatally-infected 
rats had significantly fewer Arc-positive cells in the DG compared to controls (t(29)=2.47, 
p=0.020) (Figure 9c). During the 2HR memory probe test after minimal training, there 
were no significant differences in Arc expression between groups (t(37)=1.79, p=0.082; data 
not shown). In the CA1 region, both groups had equal Arc activation (t(29)=0.394, p=0.696; 
data not shown). Both groups had equal numbers of Arc-positive cells during a single 
trial (SWIM; t(25)=−0.32, p=0.75) and had greater Arc expression overall compared to rats 
that had been trained on the task (Figure 9d). All Arc-positive cells counted in this 
experiment were also NeuN-positive (data not shown), confirming Arc expression only 
in mature neurons. 
3.3.2 Experiment 2 
3.3.2.1 Neonatal treatment did not affect acquisition of a platform location on the 
MWM during extended training. Both treatment groups performed equally on a 48HR 
memory test. 
Extensive training improved acquisition latency and memory for the platform. 
Neonatally-infected and control rats acquired the platform location during extended 
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training at the same rate and improved over days of training (F(1,56)=31.0, p<0.001) (Figure 
10a). Both groups of rats performed equally well at the 48HR memory probe test (t(46)= 
1.64, p=0.619) (Figure 10b). 
 
Figure 10: All rats exhibit similar acquisition, memory and neuronal activaton 
following extensive training. a) Both neonatally-infected rats and controls acquired 
the platform location at the same rate during extensive training (5 days of training 
with 10 trials per day) (F(1,56)= 31.0, p<0.001). b) When tested 48HR after their last 
training trial, both groups performed equally well on the probe test (t(14) = 1.08, 
p=0.298). c) When the brains of the trained rats were assessed, both groups had similar 
numbers of Arc-positive cells in the DG (t(14) = -0.781, p=0.448). d) The “yoked” rats 
that matched the trained rats in latency in the pool had similar Arc-positive cell 
counts in the DG, regardless of neonatal treatment (t(14) = -0.44, p=0.67). 
3.3.2.2 Both controls and neonatally-infected rats had similar levels of Arc activation 
in the DG during the 48HR probe following extended training. 
Both groups also had equal Arc-positive cells in the DG during the 48HR 
memory test following extended training (t(14)=−0.781, p=0.448) (Figure 10c) and the rats 
that were yoked to the extended training rats also showed equal Arc-positive cells in the 
DG (t(14)=−0.44, p=0.67) (Figure 10d). Interestingly, in contrast to minimal training (Exp. 
1), overall Arc expression in yoked rats did not differ between the trained and yoked 
groups (Figure 10, Panels c and d). 
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3.3.3 Experiment 3 
3.3.3.1 Neonatal treatment did not affect platform location acquisition on extended 
training to one platform location (NW) or a subsequent reversal platform location 
(SE). 
Reversal training after extensive training tested cognitive flexibility. Both groups 
acquired the platform location during the MWM training to both the original and 
reversal platform locations and improved over 5 and 3 days of training, respectively  
(F(4,159)=142.4, p<0.001 and F(2,95)=140.0, p<0.001, respectively) (Figure 11a). 
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Figure 11: Neonatally-infected rats are significantly impaired on a reversal 
task, despite acquisition of both the original and reversal platforms comparable to 
controls. a) Both neonatal treatment groups acquired the platform at the same rate 
during the 5 days of extensive training (F(4,159) = 142.4, p<0.001) and the 3 days of 
reversal training (F(2,95) = 140.0, p<0.001). b) Controls and neonatally-infected rats 
performed similarly on the 48HR (t(13) = 0.78, p=0.451) and 7 Day (t(13) = 0.33, p=0.745) 
memory probe tests for the original platform. After reversal training, however, 
neonatally-infected rats had an impaired memory for the reversal platform location 
(t(28) = 2.98, p=0.006). 
3.3.3.2 Both groups performed equally on memory tests to the original platform 
location, but neonatally-infected rats demonstrated a memory impairment for the 
reversal platform location. 
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For the original platform location (NW), both groups of rats performed equally 
well at the 48HR memory probe test (t(13)= 0.78, p=0.451) (Figure 11b, 48HR Platform A). 
Each group also performed equally on the 7 day memory probe test (t(13)=0.33, p=0.745) 
(Figure 11b, 7 Day Platform A). However, the neonatally-infected rats had significantly 
impaired memory for the reversal platform location during the 48HR probe (t(28)=2.98, 
p=0.006) (Figure 11b, 48HR Platform B).  
 
Figure 12: Neuronal activation does not differ between treatment groups at the 
48HR reversal probe. In spite of a behavioral difference in which neonatally-infected 
rats performed worse on the probe test, both groups had equal numbers of Arc-
positive cells in the DG during that probe (t(14) = -0.259, p=0.8). 
3.3.3.3 Both treatment groups had similar Arc activation in the DG after the 48HR 
memory probe on the reversal platform location. 
Both groups had equal counts of Arc-positive cells in the DG during the 48HR 
memory test for the reversal platform (t(14)=−0.259, p=0.8) (Figure 12).  
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3.4 Discussion 
We assessed the impact of neonatal infection on spatial learning and memory in 
adulthood, based on the growing evidence suggesting that early-life immune activation 
permanently alters the function of the hippocampus.  Following minimal training, 
neonatally-infected adult rats acquired a place memory for the water maze platform 
more efficiently than controls, whereas no group differences in acquisition or memory 
probe performance were observed following extensive training.  However, even after 
extensive training on the reversal task, neonatally-infected rats were markedly impaired 
on the 48HR memory test for the reversal platform.  Finally, neuronal activation 
assessed using Arc protein was paradoxically reduced in neonatally-infected rats in 
response to the minimally-trained platform memory probe, during which performance 
was enhanced in this group, suggesting Arc expression within the DG may correlate 
with accuracy on certain cognitive tasks and perhaps predict flexibility on future 
performance.  
The mRNA and protein level expressions of Arc have been analyzed in detail in 
the CA1 and CA3 regions of the hippocampus during spatial exploration tasks (4, 10, 12, 
265, 267, 268).  Arc activation in the CA1 and CA3 is highly correlated with place cell 
firing in the same regions during the same behavioral tasks (4, 9, 11), and Arc expression 
has become a valid correlate of cell activation in place of prior invasive in vivo studies or 
in vitro studies of the CA1 or CA3. In the DG, however, Arc expression has only recently 
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been explored. Arc expression in the DG identified newborn neurons that had matured 
and were capable of activation (269, 270). In another study, Arc mRNA and protein 
expression following two exploration bouts did not result in clear network activation in 
the DG (268). Recent work by the same group showed that renewed or continuous 
transcription within the same population of DG granule cells is responsible for sustained 
Arc expression up to 8H after an exploratory event (271). Our study is one of the first to 
examine Arc expression in the DG after a complex hippocampal-dependent task, 
assessing its correlation with memory retrieval after minimal and extensive water maze 
training paradigms. 
Significantly reduced Arc expression in the DG coupled with improved memory 
in the neonatally-infected rats after minimal training was initially surprising. However, 
recent evidence demonstrates that irradiated mice with reduced neurogenesis have 
increased Arc expression in the DG during impaired performance on a hippocampal-
dependent task (e.g. active place avoidance) (272), similar to our PBS controls.  Another 
recent study observed sustained Arc mRNA expression in the DG for hours following 
exploration and suggested BDNF release as a mechanism for this continuous expression 
(271). We have previously reported that neonatally-infected rats have reduced 
hippocampal BDNF at baseline and following fear conditioning in adulthood (222); thus, 
enduring changes in BDNF signaling may contribute to altered Arc expression in the DG 
of neonatally-infected rats in response to initial spatial learning. Reduced Arc expression 
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during a challenging task, such as the memory test following minimal MWM training, 
may be correlated to increased accuracy on hippocampal-dependent tasks. The 
minimally trained accuracy seen in the neonatally-infected rats may, however, interfere 
with memory flexibility on the reversal task. 
Alterations in neuronal circuitry may not be the primary cause for the memory 
differences we have observed between control and neonatally-infected rats. The MWM 
task is known to activate the hypothalamic-pituitary-adrenal (HPA) axis and to increase 
plasma corticosterone (CORT) levels (273).  While we did not measure CORT during or 
after the MWM task, we have shown that neonatally-infected rats have attenuated 
serum CORT levels following stressors (e.g., inescapable tail shock or restraint stress), 
but are not different from controls at baseline (228). It is possible that attenuated CORT 
levels during the acquisition of the task could have contributed to improved 
performance after minimal training or altered neuronal activation in the DG, but we are 
unable to test CORT levels in the experiments described here. In addition to changes in 
CORT responses, neonatally-infected rats demonstrate increased microglial reactivity 
within the hippocampus following fear conditioning (108). Fear conditioning causes 
increased microglial reactivity after a single trial, but we have not examined microglial 
markers or inflammatory cytokines following several days of water maze training. 
Alterations in microglial signaling could underlie the changes in neuronal activation we 
observed in the hippocampi of these rats during memory testing. In addition to changes 
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in microglia, there may be changes at the receptor level on neurons (e.g., composition of 
NMDA receptor subunits on granule cells in the DG) that we are unable to measure 
here, but we have measured Arc protein in an attempt to assess potential differences at 
the level of hippocampal circuitry in the neonatally-infected rats.  
Neonatal treatment had no effect on 48HR probe performance or DG Arc 
expression in extensively trained rats that were trained to only one platform location. To 
our surprise, the improved performance by neonatally-infected rats did not hold during 
the 48HR probe test for the reversal platform location. As we have seen previously, 
cognitive deficits in the neonatally-infected rats are often revealed following a second 
challenge in adulthood, including aging (221) and endotoxin exposure (108, 147-149). 
The cognitive challenge of reversal learning may have provided a similar “unmasking.”  
The neonatally-infected rats had significantly worse memory performance than controls 
on the behavioral task, but both groups had similar Arc-positive cells in the DG. The 
similarity in Arc expression may be the result of many trials of exposure to the same 
environment; indeed, as we observed, both minimal and extensive training on the task 
resulted in lower induced Arc expression on average compared to rats that experience a 
single trial (SWIM). The equivalent protein expression between neonatal treatment 
groups in response to reversal memory testing could also be reflective of well-
strengthened synapses that do not require the particular cellular mechanisms that Arc 
provides to maintain LTP or synaptic strength, especially after many exposures to the 
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same environment. Rats in Experiment 2 that were “yoked” by trial latencies to 
extensively trained rats had similar Arc expression in the DG compared to rats that 
learned, even without a platform as a goal. Thus, after many trials, the act of learning 
does not appear to mediate DG Arc expression further and the neural networks of the 
DG no longer correlate with behavior on spatial learning tasks.  
The lack of differences in Arc expression in DG after reversal memory testing 
may be because the alterations in signaling occur in other brain regions, such as 
prefrontal cortex and striatum that are required for reversal task learning and memory. 
The hippocampus is critical for spatial learning, but the orbitofrontal region of the 
prefrontal cortex (PFC) has been implicated in reversal learning (274-276). Furthermore, 
lesions of the medial prefrontal cortex impair reversal platform location acquisition on a 
water maze task (277). In another water maze study, lesions of the medial striatum in 
adult rats significantly impaired acquisition and memory on a reversal task (278). We 
can explore the possibilities of neural signaling changes in these regions in future 
studies. 
Future studies can also examine the specific effects of our neonatal infection 
model on these neural substrates. Others have shown that cortical circuitry is altered by 
prenatal and neonatal infection, including studies demonstrating that inflammatory 
signaling molecules inhibit dendrite development in cortical neurons in vitro (279) and 
apoptosis occurs in the prefrontal cortex, cerebellum and dentate gyrus for several 
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weeks post-inoculation with Bornavirus (280).  Infection with an AIDS-like murine virus 
(LP-BM5) impaired reversal acquisition on the water maze as well (281), indicating that 
altered immune signaling within the brain may underlie deficits on the reversal task. 
As we and others have shown, perinatal infection alters spatial learning in 
adulthood (e.g., 142, 144, 146) and may alter the underlying neural circuitry for spatial 
learning, but this hypothesis remains to be fully explored. In the hippocampus, a critical 
neural substrate for spatial learning, immune signaling molecules, such as cytokines and 
chemokines, have been implicated in synaptic formation and transmission (for review, 
see 282), offering a potential mechanism by which perinatal infection may have its 
effects on normal neural and synaptic function. Immune molecules are increasingly 
implicated in normal neural communication and any enduring changes in the 
hippocampal neural connectivity in neonatally-infected rats may underlie their distinct 
spatial learning behavior. While many of the cellular and molecular effects of neonatal 
infection remain to be elucidated, it seems that hippocampal function, especially on 
spatial learning tasks, is reliably altered by early-life immune activation. The 
examination of changes in neural circuitry are beginning to shed more light on the 
influence of the immune system within the nervous system and its effects on normal 
learning and memory, and the neonatal infection model provides a foundation with 
which we can explore the critical homeostatic functions for neuroimmune interactions in 
cognitive function. The enduring effects of such an infection demonstrate that cognitive 
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disabilities and disruptions may have their origins in the brain’s earliest days and the 
assessment of such difficulties must evaluate the entire lifespan to elucidate underlying 
causes.  
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4. Environmental enrichment alters glial antigen 
expression and neuroimmune function in the adult 
hippocampus 
4.1 Introduction 
Environmental enrichment (EE) is a housing manipulation that increases 
physical and social stimuli and is often used to modulate hippocampal plasticity and to 
rehabilitate the injured brain. The impact of EE on improved neural outcomes following 
insult is often attributed to increased neurogenesis and/or survival.  However, glia 
(microglia and astrocytes) are the primary immunocompetent cells of the brain, and 
their function is critical in both injury and repair. The functions of glia in repair may, in 
fact, be primary underlying mechanisms for improvement or rehabilitation observed 
after EE (210, 214, 218, 283).   
We examined the impact of 7 weeks of daily EE in rats on neurogenesis and glial 
alterations within the hippocampus and cortex.  We also assessed the cytokine and 
chemokine response within these regions to a peripheral immune challenge 
(lipopolysaccharide; LPS) at the end of the EE period. Notably, our enrichment protocol 
was applied prior to inflammatory insult (LPS), in contrast to the majority of studies that 
first induce injury and thereafter explore the capacity of EE to rescue cell viability or 
overall function.  Our rationale for this approach was to explore the capacity of an 
environmental change to “buffer” the neuroinflammatory potential of the brain (i.e., 
prevention rather than rehabilitation).  We report that EE specifically alters glial antigen 
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expression within the DG of the hippocampus, and markedly attenuates the immune 
response to peripheral LPS within the same region without significantly impacting 
measures of neurogenesis.  These changes were specific to the hippocampus, as the glial, 
neuronal, and cytokine responses within the cortex remained unchanged by EE.  
Notably, the blunted immune response within the hippocampus of EE rats was specific 
to a subset of cytokines and chemokines, indicating that these animals were not 
immunocompromised or deficient.  Taken together, the reduced expression of these 
particular immune molecules may lend insight into the neuroprotective phenotype of EE 
as well as the unique sensitivity of the hippocampus to inflammatory insult.     
4.2 Materials and Methods 
4.2.1 Animals and Environmental Enrichment 
Thirty-two adult (P60) male Sprague-Dawley rats were obtained from Harlan 
Laboratories (Indianapolis, IN). All rats were pair-housed upon arrival and allowed 1 
week to acclimate to the home cage environment. During the course of the experiment, 
all rats were maintained at 23°C on a 12:12-h light:dark cycle (lights on at 0700 EST) and 
given rodent chow and filtered drinking water ad libitum. After 1 week, 8 pairs were 
randomly assigned to environmental enrichment (EE) for a period of 7 weeks for 12 
hours per day during their dark cycle, while 8 pairs remained in their home cages (HC). 
This shortened EE paradigm was selected to reflect a more realistic enrichment 
intervention, in which access to EE would be limited. EE rats were placed in the same 
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enrichment boxes each day at the same time each day. They were also removed from 
their enriched environments at the same time each day and returned to their home 
cages. The enrichment boxes (55.9 cm x 35.6 cm x 30.5 cm) contained quarter-inch corn-
cob bedding (identical to home cage controls), a running wheel, a PVC tube and various 
small objects and toys. Enrichment and exercise may impact neurogenesis in the 
hippocampus differently (284); however, our aim was to maximize the effects on 
neurogenesis with both manipulations. The boxes were cleaned once weekly at the same 
time as home cage changes. All environments and conducted experiments were 
approved by the Duke University Institutional Animal Care and Use Committee.  
4.2.2 Administration of BrdU 
HC and EE rats were injected intraperitoneally (i.p.) with bromodeoxyuridine 
(BrdU) (Sigma-Aldrich; 150mg/kg), once daily for 3 days, beginning one week after the 
start of daily enrichment. This time point was chosen because previous literature 
demonstrates that key changes in neurogenesis and alterations in cell survival occur 
within the first week after plasticity-inducing conditions, such as EE or increased 
exercise (192, 285-287). Moreover, as mentioned previously, microglia play a key 
homeostatic role in neuronal survival during the first week after neurons are born in 
adulthood (105). Enrichment continued for 6 weeks after the first injection.  
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4.2.3 Adult Immune Challenge 
After 7 weeks of differential housing and 2 hours prior to sacrifice, HC and EE 
rats were injected i.p. with either sterile saline (SAL) or a 100 μg/kg dose of bacterial 
lipopolysaccharide (LPS) suspended in sterile saline. These treatments resulted in the 
four groups shown in this study: HC injected with SAL (HC-SAL), HC injected with LPS 
(HC-LPS), EE injected with SAL (EE-SAL), and EE injected with LPS (EE-LPS). 
4.2.4 Tissue Preparation 
Two hours after the SAL or LPS injections, rats were deeply anesthetized with a 
ketamine/xylazine cocktail. Prior to the start of the perfusion, blood (2ml) was collected 
by cardiac puncture and stored on ice until centrifugation. Then rats were perfused 
transcardially with saline to clear brain vessels of blood. Their brains were extracted; one 
hemisphere was placed intact into 4% paraformaldehyde solution while the 
hippocampus and parietal cortex were rapidly dissected from the remaining hemisphere 
and immediately frozen via immersion in isopentane for later RNA extraction and 
protein analysis. Intact hemispheres were alternated between post-fixation and 
dissection and equally distributed across groups. Post-fixed hemispheres were 
submerged 2 days later in 30% sucrose plus 0.1% sodium azide for cryoprotection and 
were sliced following submersion. Using a -20°C cryostat, the intact hemispheres were 
sliced into forty um coronal sections, taking 5 series of 12 sections each. Sections were 
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stored at 4°C in a 0.1% sodium azide solution until free-floating immunohistochemistry 
was performed.  
For quantitative real-time PCR, RNA was extracted from hippocampal and 
adjacent parietal cortex tissue using the Trizol method and DNAse-treated. 
Complementary DNA (cDNA) was synthesized from 100ng of isolated RNA for analysis 
of gene expression using the Qiagen QuantiTect Reverse Transcription Kit (Valencia, 
CA, USA) or from 500ng of isolated RNA using the RT2 First Strand Kit 
(SABiosciences/Qiagen, Frederick, MD, USA). 
4.2.5 Immunohistochemistry 
4.2.5.1 Basic Immunohistochemistry (IHC) Protocol 
Label-specific antibody differences are noted following this basic protocol. 
 Free-floating sections were first rinsed for 3x5 min in 0.01M phosphate buffered 
saline (PBS) and also rinsed before each subsequent step, except between the blocking 
and primary antibody steps. Next, sections were washed in 50% methanol for 30 min. 
Sections were then quenched in 0.6% hydrogen peroxide for 30 min and then blocked for 
another 30 min in 5% normal goat serum and 0.3% Triton-X to block and permeabilize, 
respectively, in PBS (blocking buffer). Sections were then incubated overnight at room 
temperature in primary antibody in blocking buffer. The following day, sections were 
incubated for 2 h at room temperature in a solution of biotinylated secondary antibody 
in blocking buffer. The Avidin-Biotin Complex (ABC) method was used to bind a 
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complex of streptavidin-biotin peroxidase to the secondary antibody (1 h incubation), 
which was then developed with diaminobenzidine (DAB, Vector Laboratories, 
Burlingame, CA, USA) for 2-15 min to produce a colorimetric stain. Sections were 
mounted on gel-coated slides, dehydrated and coverslipped with Permount.  
4.2.5.1.1 BrdU 
One series of coronal sections were stained with BrdU to quantify all newly 
dividing cells in the granule cell layer of the dentate gyrus in the hippocampus at the 
time of BrdU injections. BrdU IHC is similar to the method described above, but 
includes denaturing steps, which follow the hydrogen peroxide quenching step. 
Following quenching, sections were incubated at 65°C in 50:50 formamide:saline-sodium 
citrate (SSC) solution for 2 h and then rinsed for 2x5 min in 2X SSC. Next, sections were 
incubated in 2N HCl at 37°C in a water bath for 30 min followed by a 0.1M boric acid 
wash. The sections were then placed into blocking buffer and then the primary antibody 
buffer overnight (1:300 mouse monoclonal BrdU, Roche Diagnostics, Indianapolis, IN, 
USA). The next day for secondary antibody incubation, sections were incubated in 
biotinylated anti-mouse antibody (1:200, Vector Laboratories, Burlingame, CA. USA).  
4.2.5.1.2 DCX 
One series of coronal sections was stained with doublecortin (DCX) to identify 
immature neurons. Normal horse serum replaced normal goat serum for this stain. In 
the primary antibody step, sections were incubated with DCX antibody (1:200, goat 
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polyclonal, Santa Cruz Biotechnology, Santa Cruz, CA, USA). For the secondary 
antibody step, sections were incubated in biotinylated anti-goat antibody (1:200, Vector 
Laboratories, Burlingame, CA, USA). 
4.2.5.1.3 GFAP 
One series of coronal sections was stained with glial fibrillary acidic protein 
(GFAP) to identify astrocytes. In the primary antibody step, sections were incubated 
with GFAP antibody (1:10,000, mouse monoclonal, Chemicon International, Temecula, 
CA, USA). For the secondary antibody step, sections were incubated in biotinylated anti-
mouse antibody (1:200, Vector Laboratories, Burlingame, CA, USA).  
4.2.5.1.4 Iba1 
One series of coronal sections was stained with ionized calcium binding adaptor 
molecule 1 (Iba1) to identify microglia. For the primary antibody step, sections were 
incubated in Iba1 antibody (1:10,000, rabbit polyclonal, Wako Pure Chemical Industries, 
Ltd). In the secondary antibody step, sections were incubated in biotinylated anti-rabbit 
antibody (1:200, Vector Laboratories, Burlingame, CA, USA). 
4.2.6 Quantification 
4.2.6.1 Cell Quantification 
Quantification of BrdU-positive cells in the granule cell layer of the dentate gyrus 
in the hippocampus was performed using a Nikon Eclipse 80i microscope on a Dell PC 
running StereoInvestigator software (MBF Bioscience, Inc., Williston, VT, USA). The 
 99 
boundaries of the dentate gyrus were traced using this software at a magnification of 
10X and BrdU+ cells in the region of interest were counted at 40X. Five sections were 
counted for each rat and each section was at least 200 micrometers from the previously 
counted section. The counts from each individual section were combined to create a 
single BrdU+ cell count value per rat. Further, BrdU+ counts for rats in the same 
Housing-Treatment group were averaged to obtain a single BrdU average per group.  
4.2.6.2 Densitometry 
Quantification of GFAP-positive and Iba1-positive cells was performed using 
ScionImage densitometry. Seven sections per rat were analyzed for the dentate gyrus, 
CA1, and CA3 sub-regions of the hippocampus as well as the parietal cortex (Figure 1A). 
Digitized images of each region of interest (ROI) were taken at 20X using a Nikon 
Eclipse 80i microscope and digital camera on a Dell PC running PictureFrame software. 
Each region was traced using ScionImage after converting the image to grey scale. Signal 
pixels of an ROI were defined as having a grey value of 3 SDs above the mean grey 
value of a cell-poor area close to or within the ROI. The number of pixels and the 
average grey values above the set background were then computed for each ROI and 
multiplied by the area of the traced ROI, resulting in an integrated area density 
measurement. All values for each of the 7 sections per rat were averaged to obtain a 
single integrated density value per sub-region of interest for each rat. A two-way 
ANOVA was used to analyze the effects of Housing and Immune Challenge on the 
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individual values obtained for each rat. Integrated density values for rats in the same 
Housing-Treatment group were averaged to obtain a mean integrated density value per 
group that is shown on the graphs in Figure 15.   
 
Figure 13: Regions analyzed for density measures and representative images 
from immunohistochemical staining. All representative photomicrographs are from 
the DG of a randomly selected EE rat. a) Regions of interest for density analysis. b) 
bromodeoxyuridine (BrdU), c) doublecortin (DCX), d) glial fibrillary acidic protein 
(GFAP), and e) ionized calcium binding adaptor molecule 1 (Iba1). Scale bar = 100μm 
for images B-E. 
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4.2.6.3 Quantitative Real-Time PCR 
Gene expression was measured using quantitative real-time PCR with primers 
designed to measure 85 rat inflammatory cytokines, chemokines and receptors 
(SABiosciences/Qiagen; Cat. No PARN-011) or primers listed below using the RT2 
SYBR® Green qPCR Master Mix (Cat. No PA-010, SABiosciences/Qiagen, Frederick, MD, 
USA) following the manufacturer’s protocol. For the first method, pairs of rats from each 
treatment group were pooled into 3 samples for a final n of 3/treatment group. For the 
second method, 8 rats/group were analyzed. 
4.2.6.3.1 qRT-PCR Analysis 
Threshold amplification cycle number (Ct) was determined for each reaction 
within the linear phase of the amplification plot and relative gene expression was 
determined using the 2-ΔΔCT method (230, 231). Relative gene expression across groups 
was compared using a two-way ANOVA with housing (home cage or enrichment) and 
immune challenge (SAL or LPS) as factors. Significant interactions were followed with 
either the Holm-Sidak or Tukey’s post-hoc test with an α-level of p < 0.05 to determine 
group differences.  
4.2.6.3.2 Primer Specifications 
Real-time quantitative PCR primers were obtained from SABiosciences/Qiagen 
from Cat No. PARN-011 or designed by our laboratory and purchased from Sigma-
Aldrich (St. Louis, MO, USA). Sequences: GAPDH: Fwd – 
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GTTTGTGATGGGTGTGAACC, Rev – TCTTCTGAGTGGCAGTGATG; interleukin-1 
receptor antagonist (IL-1ra): Fwd – GTCTGGAGATGACACCAAG, Rev – 
TCGGAGCGGATGAAGGTAA; glial derived neurotrophic factor (GDNF): Fwd – 
ATTCAAGCCACCATCAAAAG, Rev – TCAGTTCCTCCTTGGTTTCG; brain-derived 
neurotrophic factor (BDNF, exon 5): Fwd – ATCCCATGGGTTACACGAAGGAAG, Rev 
– AGTAAGGGCCCGAACATACGATTG. 
4.2.7 Protein Assessment 
4.2.7.1 Multiplex 
A panel of 9 cytokines and chemokines (MCP-1, MIP-1α, IL-1β, IL-10, IFN-γ, IL-
18, GRO/KC, Rantes, and TNFα) were measured in serum with a commercially available 
Luminex bead assay (Millipore Milliplex MAP Kit, Cat# RCYTO-80K). Blood from each 
rat was clotted and centrifuged after collection. The supernatant (serum) was then 
diluted 5-fold and analyzed according to the manufacturer’s instructions. GRO/KC and 
Rantes were above the detectable range and IL-10 was below the detectable range 
following these methods; thus, these proteins were not reported. 
4.2.7.2 Corticosterone Assessment 
Total serum corticosterone concentrations were assessed in serum using a 
colorimetric EIA kit from Assay Designs, Inc. (Ann Arbor, MI). The assay was run 
according to the manufacturer’s instructions except that serum (5 μl) was diluted 1:50 in 
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0.05% steroid displacement-modified assay buffer. The detection limit of the assay was 
27 pg/ml, and the intra-assay coefficient of variation was 2.03%.  
4.2.8 Statistical analyses 
All of the analyses for this study were two-way ANOVAs comparing Housing 
(HC and EE) and Immune Challenge (SAL and LPS). F values for each analysis are 
reported in Section 3. Significant interactions were followed with either the Holm-Sidak 
or Tukey’s post hoc comparison with an α-level of p < 0.05 to determine group 
differences. 
4.3 Results 
4.3.1 Environmental enrichment increases glial marker density within 
the DG, whereas markers of neurogenesis remain unchanged. 
To assess the overall impact of EE on cell genesis/survival within the brain, we 
measured the expression of BrdU, which labels all newly dividing cells, using 
immunohistochemistry. The total number of BrdU+ cells within the DG was analyzed as 
a function of housing and LPS injection using a two-way ANOVA. Surprisingly, there 
was no effect of EE on total BrdU within the DG 6 weeks after BrdU administration 
(Figure 14a).  Thus, we also assessed expression of the immature neuronal marker DCX 
in adjacent sections. DCX expression is independent of injection time point, a factor that 
may have contributed to the lack of change in BrdU by EE.  However, there were also no 
significant changes in DCX within the DG following 7 weeks of EE (Figure 14b).  As 
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expected, we did not observe significant BrdU or DCX staining outside the DG (not 
shown).   
 
Figure 14: Daily environmental enrichment for 7 weeks does not increase cell 
survival in the dentate gyrus of the hippocampus. All rats (HC and EE) were given 
injections of BrdU one week after the beginning of the enrichment paradigm. Six 
weeks later, all rats were killed 2HR after an LPS injection. a) BrdU cell counts were 
not changed by EE and b) neither were DCX cell counts. Values are means ± SEMs of 
8 rats/group. 
To assess the impact of EE on glia, we assessed the expression of the glial 
antigens GFAP (for astrocytes) and Iba1 (for microglia). In contrast to measures of 
neurogenesis, there were increases in the density of both GFAP and Iba1 in the EE 
group. GFAP staining was increased by EE (F(1,28)=23.2, p<0.001) only in the DG sub-
region of the hippocampus and was not altered in either the CA1 or CA3 sub-regions 
(Figure 15a). Iba1 density in the DG was also significantly increased by EE (F(1,28)=23.5, 
p<0.001), as well as by LPS treatment (F(1,28)=4.45, p<0.05), an effect predominantly driven 
by the EE group (Figure 15c). Similar to GFAP, Iba1 density was not altered in either the 
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CA1 or CA3 sub-regions of the hippocampus. Furthermore, GFAP and Iba1 staining 
densities were not different in the hippocampal-adjacent parietal cortex across housing 
and treatment groups (Figure 15, b and d, respectively). 
 
Figure 15: Environmental enrichment increases glial density in the dentate 
gyrus (DG), but not in the CA1 or CA3 of the hippocampus or the adjacent parietal 
cortex. a) The density of astrocyte marker GFAP (glial fibrillary acidic protein) was 
increased in the DG of EE rats and not in HC rats. In other sub-regions of the 
hippocampus, CA1 and CA3, GFAP density was similar between the two housing 
groups. b) Additionally GFAP density in the parietal cortex adjacent to the 
hippocampus was similar in each housing group. c) The density of microglial marker 
Iba1 was increased in the DG of EE rats compared to HC rats. Iba1 density in the DG 
was also increased following an LPS injection and that effect is driven by changes in 
EE rats. Microglial density was not altered in the CA1 or CA3 regions of the 
hippocampus (c) or the parietal cortex adjacent to the hippocampus (d). Values are 
means ± SEMs of 8 rats/group. * Significantly different from home cage, p<0.05.          
** Significantly different from SAL, p<0.05. 
4.3.2 Environmental enrichment increases BDNF within the 
hippocampus 
We assessed the expression of two growth factors within the hippocampus, 
BDNF and GDNF, which are well described for their roles in neurogenesis and cellular 
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differentiation, especially during environmental enrichment (212-214, 288).  Following 7 
weeks of EE, BDNF mRNA was significantly increased within the hippocampus of EE 
rats (F(1,28)=5.7, p<0.05) (Figure 16a). In contrast, GDNF mRNA was unaffected by 
housing (p>0.05) (Figure 16b). The expression of both growth factors was reduced by 
LPS (BDNF: F(1,28)=8.8, p<0.01; GDNF: F(1,28)=10.4, p<0.01). 
 
Figure 16: Environmental enrichment increased brain-derived neurotrophic 
factor (BDNF) mRNA expression (a), but not glial-derived neurotrophic factor 
(GDNF) mRNA expression (b). Both growth factors’ expression was significantly 
reduced by LPS treatment. Values are means ± SEMs of 8 rats/group. * Significantly 
different from home cage, p<0.05. ** Significantly different from SAL, p<0.01. 
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4.3.3 Environmental enrichment attenuates the hippocampal 
response to LPS for a subset of cytokines and chemokines 
 
Figure 17: Environmental enrichment attenuates the interleukin-1β (IL-1β) 
response in the hippocampus following an LPS challenge. Rats from both housing 
groups were not different at baseline and responded to the LPS challenge. EE rats had 
a signficantly blunted increase in IL-1β mRNA expression following LPS compared to 
home cage rats. EE-LPS had significantly lower IL-1β mRNA expression compared to 
HC-LPS rats, p<0.001. Values based on means ± SEMs for 3 pairs (6 rats)/group.              
a Baseline value p>0.05. b Significantly increased from baseline, p<0.05. c Significantly 
incraesed from baseline and significantly lower than the HC rsponse, p<0.05. 
To assess the impact of EE on the central immune response to a peripheral 
inflammatory challenge, we measured inflammatory cytokine and chemokine mRNA 
expression within the hippocampus and cortex 2 hours following LPS or saline. The pro-
inflammatory cytokine interleukin-1β (IL-1β) increased within the hippocampus after 
LPS, but this increase was significantly attenuated in EE rats compared to HC (F(1,8)=42.1, 
p<0.001) (Figure 17). Additionally, mRNA expression of several members of the tumor 
necrosis factor (TNF) pathway was reduced in EE-LPS rats compared to HC-LPS: TNFα 
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(Figure 18a) (F(1,8)= 11.3, p<0.05), the receptor gene TNF receptor super family 1a 
(Tnfrsf1a, Figure 18b) (F(1,8)=5.4, p<0.05), the receptor gene TNF receptor super family 1b 
(Tnfrsf1b, Figure 18c) (F(1,8)=9.6, p<0.05), and lymphotoxin alpha (Lta or TNFβ, Figure 18d) 
(F(1,8)=17.2, p<0.005). Finally, the expression of three chemokines known primarily for 
their functions in leukocyte and monocyte recruitment was reduced in the hippocampus 
in response to LPS in the EE compared to HC rats: monocyte chemotactic protein 1 
(MCP-1/Ccl2) (F(1,8)=9.4, p<0.05), macrophage inflammatory protein 1 alpha (MIP-1α/Ccl3) 
(F(1,8)=42.1, p<0.001) and macrophage inflammatory protein 2 alpha (MIP-2α /Cxcl2) 
(F(1,8)=10.7, p<0.05) (Figure 19). For all genes listed above with the exception of Lta, 
baseline mRNA expression did not differ between saline-treated HC and EE rats.  
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Figure 18: Environmental enrichment altered the expression of several 
members of the tumor necrosis factor (TNF) family following an LPS challenge. 
Tumor necrosis factor alpha (TNFα) (a), TNF receptor super family 1a (Tnfrsf1a) (b) 
and TNF receptor super family 1b (Tnfrsf1b) (c) had significantly blunted mRNA 
expression in response to an immune challenge in EE rats. Lymphotoxin alpha (TNFβ) 
(d) was increased at baseline and its expression was reduced in EE rats following LPS. 
Values based on means ± SEMs for 3 pairs (6 rats)/group. All differences, p<0.05. 
Further assessment in the hippocampus revealed an extensive list of pro-
inflammatory cytokine, chemokine and receptor genes whose transcription increased 
following LPS treatment (main effect of LPS treatment in 2-way ANOVAs; all p’s<0.05) 
without alteration by housing (Table 1).   
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Table 1: Chemokines and cytokines in the hippcampus altered by treatment 
with LPS, regardless of housing condition. All p-values <0.05. Values based on means 
± SEMs for 3 pairs (6 rats)/group.  
Gene Reference ID HC-SAL HC-LPS EE-SAL EE-LPS 
Main 
Effect of 
LPS 
Ccl22 NM_057203 1.6±0.3 4.4±1.2 1.2±0.1 5.4±0.3 
F1,8=32.2, 
p<0.001 
Ccl7 NM_001007612 4.6±1.8 42.1±15.7 5.3±2.7 13.8±1.9 
F1,8=8.1, 
p<0.022 
Cxcl1 NM_030845 4.2±0.4 82.0±20.1 2.6±0.8 41.5±4.0 
F1,8=32.4, 
p<0.001 
Cxcl9 NM_145672 1.7±0.1 27.3±3.5 1.4±0.2 26.6±3.8 
F1,8=96.4, 
p<0.001 
Cxcl10 NM_139089 6.1±0.7 1061.2±149.7 7.7±3.6 915.5±153.3 
F1,8=83.9, 
p<0.001 
Cxcl11 NM_182952 2.5±0.3 603.4±148.3 3.1±1.4 381.9±59.8 
F1,8=37.5, 
p<0.001 
IL-1a NM_017019 3.1±0.4 1.7±0.4 3.5±0.1 1.7±0.4 
F1,8=19.5, 
p=0.002 
IL1ra NM_022194 2.8±0.4 6.4±1.5 3.3±0.8 6.5±1.8 
F1,28=10.4, 
p=0.003 
IL2rg NM_080889 1.3±0.2 7.9±0.9 1.3±0.1 6.13±0.2 
F1,8=145.9, 
p<0.001 
IL6ra NM_017020 1.3±0.1 2.4±0.1 1.2±0.1 2.0±0.2 
F1,8=52.1, 
p<0.001 
IL8rb NM_017183 2.3±0.8 9.2±4.6 1.6±0.3 7.4±1.9 
F1,8=6.1, 
p=0.039 
IL-15 NM_013129 1.5±0.1 1.3±0.2 1.6±0.1 1.1±0.1 
F1,8=5.7, 
p=0.044 
 
In contrast to the hippocampus, all gene expression changes within the parietal 
cortex adjacent to the hippocampus were due to LPS treatment alone (main effect of LPS 
treatment in 2-way ANOVAs; all p’s<0.05), without an effect of housing (Table 2). Many 
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of the same genes were upregulated following LPS treatment in both the hippocampus 
and parietal cortex. 
Table 2: Chemokines and cytokines in the parietal cortex altered by treatment 
with LPS, regardless of housing condition. All p-values <0.05. Values based on means 
± SEMs for 3 pairs (6 rats)/group. 
Gene Reference ID HC-SAL HC-LPS EE-SAL EE-LPS 
Main 
Effect of 
LPS 
Bcl6 XM_221333 1.1±0.1 1.6±0.1 1.2±0.02 1.9±0.2 
F1,8=39.5, 
p<0.001 
Ccl3 NM_013025 1.4±0.2 4.9±0.5 2.1±0.4 4.2±0.3 
F1,8=62.7, 
p<0.001 
Ccl5 NM_031116 1.4±0.3 2.4±0.5 1.6±0.2 2.5±0.4 
F1,8=6.0, 
p=0.040 
Cxcl1 NM_030845 1.3±0.3 10.9±3.2 1.3±0.02 10.5±0.8 
F1,8=32.1, 
p<0.001 
Cxcl2 NM_053647 1.8±0.2 62.8±20.2 1.8±0.7 40.0±6.2 
F1,8=21.9, 
p=0.002 
Cxcl9 NM_145672 1.6±0.3 91.0±31.1 2.3±0.3 81.8±9.6 
F1,8=26.8, 
p<0.001 
Cxcl10 NM_139089 2.0±0.7 208.8±50.0 1.7±0.3 205.8±13.5 
F1,8=63.0, 
p<0.001 
Cxcl11 NM_182952 3.4±0.9 549.3±233.8 1.7±0.5 405.2±49.1 
F1,8=15.8, 
p=0.004 
Cxcr5 NM_053303 1.2±0.3 3.8±1.0 1.4±0.2 3.5±0.7 
F1,8=13.5, 
p=0.006 
IL-1b NM_031512 2.6±0.4 29.5±10.3 2.3±0.8 19.4±3.7 
F1,8=15.9, 
p=0.004 
IL1r2 NM_053953 1.4±0.4 3.0±0.6 1.7±0.2 2.2±0.1 
F1,8=8.4, 
p=0.02 
IL2rg NM_080889 1.5±0.2 7.2±1.0 1.1±0.04 6.1±0.4 
F1,8=95.0, 
p<0.001 
IL6ra NM_017020 1.1±0.04 2.6±0.3 1.2±0.03 2.2±0.2 
F1,8=44.2, 
p<0.001 
IL8ra NM_019310 3.0±0.9 6.6±1.1 2.2±0.8 7.0±0.6 
F1,8=23.5, 
p=0.001 
IL8rb NM_017183 2.1±0.8 7.5±1.8 1.5±0.3 6.4±1.3 F1,8=18.9, 
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p=0.002 
IL-11 NM_133519 1.3±0.2 2.3±0.3 1.5±0.1 1.9±0.3 
F1,8=9.7, 
p=0.014 
IL-15 NM_013129 1.6±0.03 1.2±0.1 2.0±0.1 1.3±0.2 
F1,8=13.7, 
p=0.006 
Lta NM_080769 2.1±0.5 3.4±0.4 1.6±0.6 2.6±0.4 
F1,8=5.5, 
p=0.046 
Tnfrsf1b NM_130426 1.3±0.2 2.9±0.4 1.3±0.1 2.4±0.1 
F1,8=43.5, 
p<0.001 
 
Many of the same genes were upregulated following LPS treatment in both the 
hippocampus and parietal cortex. 
 
Figure 19: Following an LPS challenge, environmental enrichment altered the 
expression of several chemokines – monocyte chemotactic protein 1 (MCP-1/Ccl2) (a), 
macrophage inflammatory protein 1 alpha (MIP-1α/Ccl3) (b), and macrophage 
inflammatory protein 2 alpha (MIP-2α/Cxcl2) (c). All 3 chemokines had significantly 
blunted mRNA expression in EE-LPS rats compared to HC-LPS rats, p<0.05. a Baseline 
value, p<0.05. b Significantly increased from baseline (a), p<0.05. c Significantly 
increased from baseline and significantly lower than HC response. Values based on 
means ± SEMs for 3 pairs (6 rats)/group.  
4.3.4 Environmental enrichment does not impact the peripheral 
immune or corticosterone response to LPS 
We assessed a panel of 9 inflammatory cytokine and chemokine proteins within 
the serum using a Luminex bead-based assay, to determine whether the impact of EE on 
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the immune response to LPS was specific to brain.  Each of the proteins assessed was 
also measured at the mRNA level within the brain (as discussed previously), though we 
were only able to measure a small subset of proteins in serum due to the limited 
availability of rat-specific analytes for the Luminex technology.  We did not use 
Luminex to assess protein expression within brain tissue, as this technology has not been 
validated for rat brain and in our hands generated many high false positives (e.g., on the 
upper end of detection) without a significant LPS effect (data not shown).  In short, we 
do not believe the measurements are accurate.   
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Figure 20: In the periphery, LPS treatment significantly increased protein 
expression in the serum of the following cytokines and chemokines: interleukin-1β 
(IL-1β) (a), tumor necrosis factor alpha (TNFα) (b), monocyte chemotactic protein 1 
(MCP-1/CCL2) (c), and macrophage inflammatory protein 1 alpha (MIP-1α/CCL3) (d). 
Values are means ± SEMs of 8 rats/group. * Significantly different than SAL, p<0.005. 
Our protein assessments in serum showed only an effect of LPS for each protein without 
an effect of housing. IL-1β (Figure 20a, p<0.001), TNFα (Figure 20b, p<0.005), MCP-1 
(Ccl2) (Figure 20c, p<0.001) and MIP1α (Ccl3) (Figure 20d, p<0.001) were equally 
increased in the periphery, regardless of housing condition, unlike their responses 
within the hippocampus. Serum corticosterone, which can markedly impact pro-
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inflammatory cytokine expression, was also increased by LPS treatment in all rats, 
without an effect of housing condition (F(1,28)=276.3, p<0.001) (Figure 21). 
 
Figure 21: An immune challenge with LPS significantly increased serum 
corticosterone, regardless of housing group. Baseline corticosterone was not altered 
by housing. Values are means ± SEMs of 8 rats/group. * Significantly different from 
SAL, p<0.001. 
4.3.5 Environmental enrichment increases CD200 expression, but 
does not alter the expression of CD200R, fractalkine (CX3CL1) and 
fractalkine receptor (CX3CR1). 
To assess the effects of EE on neuron-glia interactions, we measured mRNA 
expression from the same hippocampal tissue assessed above in Figures 16-19. Neurons 
have direct contact with microglia and can alter their reactivity (234, 235).  We did not 
measure any group differences in fractalkine (CX3CL1) expression or in the expression 
of its receptor (CX3CR1).  
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Figure 22: Fractalkine signaling is not altered by environmental enrichment. a) 
Fractalkine (CX3CL1) mRNA expression is not different between housing groups or 
treatment conditions. b) Fractalkine receptor (CX3CR1) expression is not altered in 
any treatment groups. 
CD200 expression was not altered by housing or LPS treatment, but expression of its 
receptor, CD200R, was significantly increased in the hippocampi of EE rats (F(1,28)=6.64, 
p=0.016). 
 
Figure 23: Environmental enrichment alters expression of CD200 receptor. a) 
CD200 mRNA expression is not different between housing and treatment groups. b) 
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CD200 receptor (CD200R) expression is increased in EE rats. * Significantly different 
from home cage (p<0.05). 
4.4 Discussion 
The hippocampus has long been considered to have increased plastic potential 
compared to other cortical regions, but with its increased plasticity may come 
augmented vulnerability. Cytokine receptors are distributed throughout the brain, but 
have one of the highest densities in the hippocampus (54, 289). The hippocampus also 
exhibits marked vulnerability (e.g., cell death and neural dysfunction) relative to other 
brain regions in response to diverse threats to homeostasis, including stress, epilepsy, 
stroke, and cardiac arrest (290-293).  Thus the hippocampus may be particularly 
sensitive to immune-related alterations (294, 295). The adjacent parietal cortex that lies 
dorsal to the hippocampus is responsive to LPS (108); however, the neocortex and 
hippocampus differ dramatically in structure, connectivity and function. The finding 
that EE did not affect the neuroimmune response in the parietal cortex, whereas it had a 
dramatic effect in the hippocampus, underscores the distinction of the hippocampus 
from other cortical structures.  
Environmental enrichment is a well-established protocol for altering the 
neurogenic niche of the subgranular zone (SGZ) of the DG of the hippocampus. We 
hypothesized that EE, which induces neuroprotection in a number of studies (214, 217, 
296, 297), would attenuate the neuroinflammatory response to a peripheral immune 
challenge.  Finally, we predicted that EE would impact not only neurogenesis but glia as 
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well, as shown in limited studies (209, 211, 298). Glia are the likely source of the 
neuroinflammatory cytokines and chemokines of interest, and the impact of EE could 
potentially alter these signaling molecules. We observed a markedly reduced pro-
inflammatory phenotype within the brains of EE rats compared to controls, evidenced 
by the selective attenuation of a subset of cytokines and chemokines following 
peripheral LPS.  This attenuation was restricted to the hippocampus, and coincident 
with increased expression of the glial antigens Iba1 and GFAP.  Surprisingly, however, 
these changes were independent of increased neurogenesis, which we did not observe 
when assessed using BrdU given after 1 week of EE, or with the immature neuronal 
marker DCX after 7 weeks of EE.   
Interestingly, neurogenesis itself is not required for cognitive improvements 
following enrichment (as shown by 299). Our enrichment paradigm was similar in 
duration by total days to many other studies (for meta-analysis, see 300), but few, if any, 
other studies alter housing solely during the dark cycle as we did in this study to more 
accurately model a “real-world” intervention. It is possible that this paradigm is more 
stressful than full-time housing; however, we did not observe any significant differences 
in corticosterone between home cage and EE rats.  It is also possible that extending our 
enrichment paradigm to either full time housing or 10 to 12 weeks of limited daily 
enrichment would increase the population of immature neurons measured by DCX 
staining, based on prior findings in the field. Our paradigm did, however, elicit other 
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enduring changes in the hippocampi of EE rats.  EE increased BDNF mRNA overall 
within the hippocampus, despite the acute suppression in response to LPS, which are 
both consistent with the literature (154, 213, 301, 302). Most strikingly, EE increased the 
density of both Iba1 and GFAP expression specifically within the DG, consistent with a 
previous report that wheel running exercise increases astrogliogenesis (209). Our 
densitometry assessments do not allow conclusions regarding gliogenesis or number of 
cells; however, the lack of change in total BrdU strongly argues against an increase in the 
number of new glia in EE rats.  The data instead suggest that EE changes the phenotype of 
glia, altering their activation and attenuating their pro-inflammatory response to 
peripheral LPS, although this remains to be directly tested. Interestingly, the blunted 
neuroinflammatory response within the DG of EE rats occurring concomitant with the 
increase in classical glial “activation” markers runs counter to our initial prediction. 
However, we believe these data simply highlight the fact that little is known about the 
function of these markers. Moreover, there is a growing literature that distinguishes 
classical versus alternative activation states in microglia, the latter of which is associated 
more strongly with repair (73, 164). Thus, it is possible that EE shifts microglia into an 
alternatively activated phenotype, an intriguing possibility that we are currently 
exploring. Regardless of whether glial number or phenotype is influenced, the notable 
finding is that there is clearly an impact of EE on glia that occurs without any discernible 
change in newborn neurons.  Importantly, glia were not changed in the CA1 or CA3 
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sub-regions of the hippocampus, nor were they altered in the adjacent parietal cortex, 
suggesting that the microenvironment of the DG is conducive to glial changes which 
may occur independent from neurogenesis. Indeed, glial plasticity may directly interact 
with and alter neuronal plasticity, questions that remain to be explored.  
The immune response within the hippocampi of EE rats was markedly 
attenuated for a subset of cytokines and chemokines measured in our study. 
Importantly, not all measured immune molecules were blunted in the hippocampi of EE 
rats. Furthermore, the immune response was similar for each housing group in the 
parietal cortex as well as in the periphery. Within the hippocampus, however, EE rats 
had an attenuated response of interleukin-1β (IL-1β), the TNF family of genes, and 
several chemokines involved in the recruitment of leukocytes and monocytes. These 
families of genes indicate an altered hippocampal milieu in EE rats that may be less pro-
inflammatory, more neuroprotective and less permeable to peripheral infiltrating 
immune cells.  
As several studies, including our own, have shown, IL-1β is a pro-inflammatory 
molecule that is also important for normal brain function (52, 57, 154, 303-305). 
Importantly, physiological levels of IL-1β expression are critical for normal learning and 
memory (57), whereas levels that are either too low or too high become detrimental 
(108). In the present study, EE rats have a blunted IL-1β response to an LPS dose that 
elicits a robust increase in mRNA expression in HC controls. Numerous other studies 
 121 
have demonstrated improved learning and memory performance in EE rats (299, 300, 
306-310).  Notably, the source of IL-1β during hippocampal-dependent learning, as well 
as during an immune response within the hippocampus, is solely CD11b+ microglia 
(108). Altered microglial reactivity in response to EE may therefore have significant 
consequences for learning and memory processes, especially in the context of infection 
or illness, which remains to be explored. Similarly, many studies use EE as a 
rehabilitation paradigm in a diseased brain model (e.g., Parkinson’s disease, (296)); in 
these studies, IL-1β tone may exceed optimal levels in the inflamed, diseased brains 
without an EE intervention.  
Tumor necrosis factor alpha (TNFα) is well characterized for its roles in 
inflammation and host defense, sepsis and, most intriguing for this study, apoptosis 
cascades (for review, see 311). The observed attenuation after an immune challenge of 
TNFα and several associated genes in EE rats compared to HC controls indicates a 
potential enduring change in the hippocampal microenvironment of enriched rats, such 
that one mechanism by which EE may increase neuroprotection following insults to the 
CNS (214, 217, 296) is via altered TNF tone and function, increasing the likelihood of cell 
survival by reducing apoptotic signaling. In addition to attenuated IL-1β and TNF 
responses, EE rats showed blunted responses for several chemokines known to influence 
the recruitment of circulating monocytes and leukocytes to the CNS. Monocyte 
chemoattractant protein-1 (MCP-1/CCL2) is important for recruitment of peripheral 
 122 
monocytes into the brain during an immune challenge or infection (e.g. HIV; (312)). 
Following status epilepticus (SE) in rats, triggered by stimulation of the amygdala, a 
paradigm known to increase aberrant neurogenesis and neuronal injury in the 
hippocampus, macrophage inflammatory protein 1-alpha (MIP-1α/CCL3) is increased 
for up to 30 days (313). Taken together, the attenuated expression of these cytokines and 
chemokines in EE rats treated with LPS demonstrate possible mechanisms for 
neuroprotective and increased plasticity outcomes associated with EE.  
In addition to attenuated expression of pro-inflammatory cytokines and 
chemokines, there was a change in CD200 receptor, which mediates interactions 
between neurons and microglia. While fractalkine (CX3CL1) and its receptor (CX3CR1) 
were not altered by EE, CD200R expression was increased in EE rats, regardless of 
immune challenge. Greater expression of CD200R, which potentially increases the 
sensitivity of microglia to neural signals via CD200, is the converse of our previous 
finding in the neonatally infected rats following fear conditioning (Chapter 2 and (108)). 
The increase in CD200R could be one mechanism by which microglial reactivity is 
attenuated by EE, though the mechanisms that cause this increase are yet unknown. 
In summary, environmental enrichment is a relatively simple manipulation that 
results in robust beneficial outcomes for the brain. While previous studies have shown a 
role in post-insult rehabilitation for EE, our study provides evidence that enrichment 
need not follow the insult in order to be beneficial.  Indeed, neuroinflammatory disease 
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states might be attenuated or delayed in their onset in the face of ongoing EE. The 
translational reach of this manipulation remains to be explored, but in animal models of 
neuroinflammation, EE may provide a simple preventative measure for negative 
outcomes. Furthermore, this study presents further evidence that EE alters microglia 
and astrocytes within the DG of the hippocampus. Though the mechanism remains to be 
investigated, these changes in glia in the DG may underlie the attenuated immune 
response in the brains of EE rats treated with LPS, and these same glial changes may be 
directly related to neural changes often associated with EE. As an increasing number of 
studies explore the effects of glia (both microglia and astrocytes) on normal brain 
function, manipulations that alter both glia and neurons alike may provide perspective 
on interactions between these cell types as well as their specific roles in the healthy 
brain. 
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5. Environmental enrichment alters the neurogenic 
niche: altered microglial reactivity requires interactions 
with other neural cell types 
5.1 Introduction 
The previous work on environmental enrichment (Chapter 4) demonstrated that 
EE prior to immune challenge increases glial antigen density (e.g., GFAP, Iba1) within 
the dentate gyrus, increases growth factors within the hippocampus and decreases pro-
inflammatory signaling within the hippocampus at the transcription level following the 
peripheral immune challenge. While compelling, these data did not reveal which cell 
types were most affected by EE. This study sought to test the hypothesis that 
hippocampal microglia are altered by EE, which leads to the changes in Iba1 expression 
and/or changed microglial cell number as well as the attenuated cytokine and 
chemokine response within the hippocampus. Furthermore, the effects seen on 
astrocytes in the earlier EE experiment did not address changes in cell number in that 
population, which this study aimed to address.  
In order to assess microglial function, they were isolated from other cell types in 
the hippocampus and treated ex vivo with an immune activator, lipopolysaccharide 
(LPS). LPS binds directly to toll-like receptor 4 (TLR4) on microglia and elicits a pro-
inflammatory cascade of cytokines and chemokines. We predicted that a phenotypic 
change in microglia would be demonstrated by an attenuated secretion of inflammatory 
cytokines and chemokines, similar to the pattern we observed in the previous EE 
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experiment. In addition to the cell culture ex vivo manipulation, we used the other half of 
the brain to assess cell number of both microglia (Iba1+) and astrocytes (GFAP+), using 
immunohistochemical methods. With microglia, we could measure soma size in 
addition to cell number to determine any morphological alterations caused by EE 
without the influence of a peripheral immune challenge. These experiments would 
allow us to fully characterize the effects of EE on the glial cells of the hippocampus and 
provide potential mechanisms by which our previous results might occur.  
5.2 Materials and Methods 
5.2.1 Animals and Environmental Enrichment 
Twenty-four adult (P60) male Sprague-Dawley rats were obtained from Harlan 
Laboratories (Indianapolis, IN). All rats were pair-housed upon arrival and allowed 1 
week to acclimate to the home cage environment. During the course of the experiment, 
all rats were maintained at 23°C on a 12:12-h light:dark cycle (lights on at 0700 EST) and 
given rodent chow and filtered drinking water ad libitum. After 1 week, 6 pairs were 
randomly assigned to environmental enrichment (EE) for a period of 7 weeks for 12 
hours per day during their dark cycle, while 6 pairs remained in their home cages (HC). 
This shortened EE paradigm was selected to mimic the housing of Experiment 4 as a 
realistic intervention and to assess the effects of this type of enrichment on other 
outcomes. EE rats were placed in the same enrichment boxes each day at the same time 
each day. They were also removed from their enriched environments at the same time 
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each day and returned to their home cages. The enrichment boxes (55.9 cm x 35.6 cm x 
30.5 cm) contained quarter-inch corn-cob bedding (identical to home cage controls), a 
running wheel, a PVC tube and various small objects and toys. Enrichment and exercise 
may impact neurogenesis in the hippocampus differently (284); however, our aim was to 
maximize the effects on neurogenesis with both manipulations. The boxes were cleaned 
once weekly at the same time as home cage changes. All environments and conducted 
experiments were approved by the Duke University Institutional Animal Care and Use 
Committee.  
5.2.2 Tissue Preparation 
On the last day of enrichment, rats were deeply anesthetized with a 
ketamine/xylazine cocktail. Then rats were perfused transcardially with saline to clear 
brain vessels of blood. Their brains were extracted; one hemisphere was placed intact 
into 4% paraformaldehyde solution while the hippocampus and parietal cortex were 
rapidly dissected from the remaining hemisphere. Each dissected brain region was 
placed into an individual well in 2ml HBSS (Hanks Balanced Salt Solution; w/o Mg+2 and 
Ca+2; Invitrogen) in a 6-well plate and taken for microglial isolation (see 5.2.3). Intact 
hemispheres were alternated between post-fixation and dissection and equally 
distributed across groups. Post-fixed hemispheres were submerged 2 days later in 30% 
sucrose plus 0.1% sodium azide for cryoprotection and were sliced following 
submersion. Using a -20°C cryostat, the intact hemispheres were sliced into 40 um 
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coronal sections, taking 5 series of 60 to 70 sections each. Sections were stored at 4°C in a 
0.1% sodium azide solution until free-floating immunohistochemistry was performed.  
5.2.3. Microglia Isolation 
Isolated hippocampi and parietal cortex regions were sliced into small pieces 
using a sterile razor and transferred into a 2 ml sterile tube with 1 ml of HBSS (w/o) 
(Invitrogen), which was spun at 300 X g at room temperature for 2 min. The tissue was 
then brought to a single-cell suspension using Miltenyi’s Neural Tissue Dissociation Kit 
(P) (Miltenyi Biotec) in MACS buffer (PBS containing 0.5% BSA and 2 mM EDTA, pH 
7.2) for 15 min at 4°C. The tissue was passed through a 70 μm Nitex nylon filter and 
resuspended in 10 ml of HBSS (w/ Mg+2 and Ca+2; Invitrogen). The tissue was then 
centrifuged at 300 X g at 4°C for 10 min. After the supernatant was aspirated, the tissue 
was resuspended in 30% Percoll (GE Healthcare Life Sciences, Pittsburgh, PA) and 
centrifuged at 700 X g at 4°C for 10 min. The remaining pellet (demyelinated cells) were 
washed with 5 ml HBSS (w/o) and centrifuged at 300 X g at 4°C for 10 min. The 
demyelinated cells were further fractionated based on CD11b expression as follows 
(5.2.3.1).  
5.2.3.1 MACS enrichment of CD11b+ cells 
Cells were resuspended in 250 µl of MACS buffer, stained with 2.5 µl of PE-
conjugated mouse anti-rat CD11b/c beads (BD Biosciences Pharmingen) and incubated 
for 10 min in the dark at 4°C. The cells were washed with 1 ml of MACS buffer and 
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centrifuged at 300 X g at 4°C for 10 min. Cells were then incubated in 200 μl MACS 
buffer with 50 μl anti-PE MicroBeads (Miltenyi Biotec) at 4°C for 10 min. The suspension 
was washed with 5 ml of MACS buffer and centrifuged at 300 X g at 4°C for 10 min, and 
the supernatant was aspirated off. The cells were resuspended in 500 µl of MACS buffer 
and were passed through a nylon mesh filter onto magnetized LS columns (Miltenyi 
Biotec). The columns were washed with 4 ml of MACS buffer and the flow through was 
collected into a clean 15 ml conical (as CD11b/c-negative fraction). Magnetically labeled 
CD11b/c-positive cells were flushed out of the columns twice with MACS buffer into a 
clean 15 ml conical. Magnetically enriched cell fractions were centrifuged at 300 X g at 
4°C for 10 min, followed by resuspension of CD11b+ cells in high-glucose (4.5 g/L) 
DMEM. Isolated CD11b+ cells were then placed into culture as follows (see 5.2.3.2). 
Isolated CD11b/c-negative cells were resuspended in 500 μl PBS and centrifuged at 300 X 
g at 4°C for 5 minutes. After aspiration, CD11b/c-negative cell pellets were flash-frozen 
at -80°C until processing for RT-PCR. 
5.2.3.2 Ex vivo LPS stimulation 
Isolated CD11b+ cells were suspended in Neuro Media (high-glucose (4.5 g/L) 
DMEM supplemented with 1% Pen-Strep (GIBCO, Life Technologies, Grand Island, 
NY), 2mM L-glutamine (GIBCO), 1mM sodium pyruvate (GIBCO), 1% N2 supplement 
(GIBCO), 10% fetal bovine serum (FBS; Hyclone, Thermo Fisher Scientific, Waltham, 
MA) and 5 µg/ml forskolin (Sigma-Aldrich, St. Louis, MO)). Cells were incubated with 
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LPS (10 ng/ml) or media alone for 4 h at 37°C, 5% CO2. For each condition, samples were 
run in duplicate. At the end of incubation, the plate was centrifuged at 1000 X g for 10 
min at 4°C to pellet cells. Supernatant for each sample was collected and frozen at -20°C. 
The cell pellet was resuspended in 300 μl PBS, centrifuged at 350 X g for 10 min at 4°C, 
and the resulting pellet was flash frozen at -80°C until processing for RT-PCR.   
5.2.4 Immunohistochemistry 
5.2.4.1 Basic Immunohistochemistry (IHC) Protocol 
Label-specific antibody differences are noted following this basic protocol. 
 Free-floating sections were first rinsed for 3x5 min in 0.01M phosphate buffered 
saline (PBS) and also rinsed before each subsequent step, except between the blocking 
and primary antibody steps. Next, sections were washed in 50% methanol for 30 min. 
Sections were then quenched in 0.6% hydrogen peroxide for 30 min and then blocked for 
another 30 min in 5% normal goat serum and 0.3% Triton-X to block and permeabilize, 
respectively, in PBS (blocking buffer). Sections were then incubated overnight at room 
temperature in primary antibody in blocking buffer. The following day, sections were 
incubated for 2 h at room temperature in a solution of biotinylated secondary antibody 
in blocking buffer. The Avidin-Biotin Complex (ABC) method was used to bind a 
complex of streptavidin-biotin peroxidase to the secondary antibody (1 h incubation), 
which was then developed with diaminobenzidine (DAB, Vector Laboratories, 
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Burlingame, CA, USA) for 2-15 min to produce a colorimetric stain. Sections were 
mounted on gel-coated slides, dehydrated and coverslipped with Permount.  
5.2.4.1.1 GFAP 
One series of coronal sections was stained with glial fibrillary acidic protein 
(GFAP) to identify astrocytes. In the primary antibody step, sections were incubated 
with GFAP antibody (1:10,000, mouse monoclonal, Chemicon International, Temecula, 
CA, USA). For the secondary antibody step, sections were incubated in biotinylated anti-
mouse antibody (1:200, Vector Laboratories, Burlingame, CA, USA).  
5.2.4.1.2 Iba1 
One series of coronal sections was stained with ionized calcium binding adaptor 
molecule 1 (Iba1) to identify microglia. For the primary antibody step, sections were 
incubated in Iba1 antibody (1:10,000, rabbit polyclonal, Wako Pure Chemical Industries, 
Ltd). In the secondary antibody step, sections were incubated in biotinylated anti-rabbit 
antibody (1:200, Vector Laboratories, Burlingame, CA, USA). 
5.2.5 Cell Quantification 
Quantification of Iba1-positive cells in the dentate gyrus in the hippocampus was 
performed using a Nikon Eclipse 80i microscope on a Dell PC running 
StereoInvestigator software (MBF Bioscience, Inc., Williston, VT, USA). The boundaries 
of the dentate gyrus were traced using this software at a magnification of 4X and Iba1+ 
cells in the region of interest were counted at 100X (oil). Five sections were counted for 
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each rat and each section was at least 200 micrometers from the previously counted 
section. Unbiased stereology was used to estimate the total numbers of Iba1+ cells. Cell 
numbers were estimated using the Cavalieri principle and the optical dissector method, 
with a 2mm guard zone. Microglial volumes were estimated using 5 rays of independent 
isotropic probes within the “Nucleator” function of the StereoInvestigator software. 
Estimated cell counts were calculated by the Mean Measured Section Thickness 
multiplied by total counts in 5 representative sections and the section periodicity (5) 
within StereoInvestigator to create a single Iba1+ estimated cell count per rat. Estimated 
volumes were calculated based on measured section volumes and section periodicity (5) 
to create a single estimated volume value per rat. The volumes of individually marked 
cells in the “Nucleator” function were averaged within a section and then averaged 
across sections for a single average cell volume measurement for each rat. 
5.2.6 Quantitative Real-Time PCR 
Gene expression was measured using quantitative real-time PCR with primers 
listed below using the RT2 SYBR® Green qPCR Master Mix (Cat. No PA-010, 
SABiosciences/Qiagen, Frederick, MD, USA) following the manufacturer’s protocol. The 
CD11b-negative population from the hippocampi of 12 rats/group was analyzed. 
5.2.6.1 RNA Isolation, cDNA Synthesis and RT-PCR 
Total RNA was isolated based on the TRIzol method (229). To increase mRNA 
yield from isolated cell samples, glycogen (Invitrogen, Life Technologies, Grand Island, 
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NY) was added at the isopropanol step.  Following RNA isolation and enrichment, 
samples were DNase-treated, and cDNA was synthesized using the reverse 
transcriptase kit from QIAGEN. Amplification of cDNA was performed using a 
QuantiFast SYBR Green PCR kit (QIAGEN) on a Mastercycler ep realplex (Eppendorf). 
cDNA (1.5 µg in 1 µl) was added to a reaction master mix (12 µl) containing HotStarTaq 
Plus DNA Polymerase, QuantiFast Buffer, SYBR Green I, Passive reference dye, and 
gene-specific primers (500 nM each of forward and reverse primer).  
5.2.6.2 qRT-PCR Analysis 
Threshold amplification cycle number (Ct) (number of cycles to reach threshold 
of detection) was determined for each reaction within the linear phase of the 
amplification plot and relative gene expression was determined using the 2-ΔΔCT method 
(230, 231). Relative gene expression across groups was compared using a one-way 
ANOVA with housing (home cage or enrichment) as the factor.  
5.2.6.3 Primer Specifications 
Real-time quantitative PCR primers were designed by our laboratory and 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Sequences: GAPDH: Fwd – 
GTTTGTGATGGGTGTGAACC, Rev – TCTTCTGAGTGGCAGTGATG; CD200: Fwd – 
TGTTCCGCTGATTGTTGGC, Rev – ATGGACACATTACGGTTGCC; CX3CL1: Fwd – 
TCCAGGGCTGTCCCCGCAAA, Rev - ACAGGCAGGCAAGCAGGCAG  
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5.2.7 Multiplex 
A panel of 9 cytokines and chemokines (CCL2/MCP-1, CCL3/MIP-1α, 
CXCL2/MIP-2α, CXCL5/LIX, IL-1α, IL-1β, IL-10, IL-18, and TNFα) were measured in the 
supernatant from the ex-vivo cell culture procedure with a commercially available 
Luminex bead assay (Millipore Milliplex MAP Kit, Cat# RCYTMAG-65K). The 
supernatant was analyzed according to the manufacturer’s instructions. CXCL5 was 
below the detectable range following these methods; thus, this protein was not reported. 
5.2.8 Statistical analyses 
Analyses for immunohistochemistry were one-way ANOVAs comparing 
Housing (HC and EE). Analyses for multiplex were three-way ANOVAs with brain 
region (HP vs. PAR) housing (home cage vs. enrichment) and culture treatment (media 
vs. LPS) as factors followed by two-way ANOVAs based on interactions.  F values for 
each analysis are reported in Section 5.3.  
5.3 Results 
5.3.1. Environmental enrichment reduces microglia volumes in the 
dentate gyrus compared to controls, but does not alter the number of 
microglia.  
In previous work on environmental enrichment (Chapter 4), we assessed the 
expression of Iba1 with densitometry, a measure that does not determine numbers of 
cells or changes in antigen expression at the level of single cells (314). Based on the 
increase in Iba1 density, we performed unbiased stereology in conjunction with the 
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Nucleator function in the dentate gyrus to determine cell number and individual cell 
volumes. Estimated cell counts of Iba1+ cells were not different between enriched and 
home cage rats (Figure 22a; F(1,22) =0.03, p=0.86). Estimated total region volumes 
calculated during stereology were not different between housing groups (Figure 22b; 
F(1,22)=0.72, p=0.41). However, average cell volume as calculated by the Nucleator 
function (soma size X factor of section thickness) was reduced in the DG regions of 
enriched rats compared to home cage controls (Figure 22c; F(1,22)=4.35, p=0.048).  
 
Figure 24: Microglial soma size is reduced in the DG of enriched rats, but total 
cell counts are not altered. a) Home cage and enriched rats have the same number of 
Iba1+ cells within the DG. b) Both housing conditions have similar DG volumes. c) 
Microglia volume is reduced in the DG of enriched rats, but not home cage controls. 
*Significantly less than Home Cage, p<0.05 
5.3.2. Environmental enrichment does not alter the number of GFAP+ 
astrocytes within the dentate gyrus.  
Similar to Iba1 antigen expression in Chapter 4, GFAP density was increased in 
the DG of enriched rats.  Based on this increase, we performed unbiased stereology in 
the dentate gyrus to determine cell numbers of GFAP+ cells. Estimated cell counts of 
GFAP+ cells were not different between enriched and home cage rats (Figure 23a; F(1,22) 
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=0.18, p=0.68). Estimated total region volumes calculated during stereology were not 
different between housing groups (Figure 23b; F(1,22)= 0.01, p=0.92).  
 
Figure 25: Total GFAP+ cell counts are not different between housing groups. 
a) Home cage and enriched rats have the same number of GFAP+ cells within the DG. 
b) Both housing conditions have similar DG volumes.  
5.3.3. Isolated hippocampal and parietal cortical microglia from 
enriched rats do not differ in their cytokine response to ex-vivo LPS 
stimulation in culture. 
We assessed a panel of 9 inflammatory cytokine and chemokine proteins within 
the cell culture supernatant using a Luminex bead-based assay, to determine whether 
the impact of EE altered the intrinsic reactivity of microglia within the hippocampus and 
adjacent parietal cortex. Our protein assessments in supernatant showed only an effect 
of LPS for each protein without an effect of housing. In hippocampal microglia, IL-1β 
(Figure 24a; F(1,44) = 15.36 p=0.0003) and IL-10 (Figure 25a; F(1,44)=15, p=0.0004) were 
equally increased in response to LPS, regardless of housing condition.  
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Figure 26: Isolated microglia from home cage and enriched rats had similar IL-
1β responses to LPS in culture. a) IL-1β expression is increased in isolated 
hippocampal microglia exposed to LPS in culture, regardless of housing condition. b) 
IL-1β expression is increased in isolated microglia from the parietal cortex that were 
exposed to LPS in culture, regardless of housing condition. *Significantly greater than 
Media, p<0.05 
Similarly in microglia isolated from the parietal cortex, IL-1β (Figure 24b; F(1,44) = 14.9 
p=0.0004) and IL-10 (Figure 25b, F(1,44)=23.9, p<0.0001) were equally increased in 
response to LPS in both home cage and enriched rats.  
 
Figure 27: Isolated microglia from home cage and enriched rats had similar IL-
10 responses to LPS in culture. a) IL-10 expression is increased in isolated 
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hippocampal microglia exposed to LPS in culture, regardless of housing condition. b) 
IL-10 expression is increased in isolated microglia from the parietal cortex that were 
exposed to LPS in culture, regardless of housing condition. *Significantly greater than 
Media, p<0.05 
In addition to changes in IL-1β and IL-10, IL-1α, MIP-1α (CCL3), MIP-2α 
(CXCL2), and TNFα expression was increased in hippocampal following LPS treatment 
(main effect of LPS treatment in 2-way ANOVAs; all p’s<0.05) without alteration by 
housing (Table 3).  There were no significant differences in expression of IL-18 and 
MCP-1 (CCL2) between culture treatment or between housing groups (p>0.05).  
Table 3: Chemokines and cytokines in CD11b+ isolated from the hippocampus 
altered by treatment with LPS with no effect of housing condition. All p-values<0.05. 
Values based on means ± SEMs for 12 rats/group. 
Protein HC-Media HC-LPS EE-Media EE-LPS 
Main Effect 
of LPS 
IL-1α 6.6±1.6 28.7±2.8 4.2±0.4 31.5±6.4 
F1,44=47.6, 
p<0.001 
MIP-1α 156.5±37.1 310.5±30.8 121.6±21.1 273.6±35.2 
F1,44=23.4, 
p<0.001 
MIP-2α 292.4±62.2 1212.3±105.4 190.3±32.4 995.5±134.9 
F1,44=86.9, 
p<0.001 
TNFα 3.4±0.7 41.9±5.3 2.7±0.6 36.4±5.3 
F1,44=92.4, 
p<0.001 
 
The same pattern of expression in response to LPS occurred in microglia isolated from 
the parietal cortex (Table 4). Notably, the cytokine response from microglia in the 
parietal cortex was significantly greater than hippocampal microglia for several proteins: 
IL-1α (F(1,88)=4.16, p=0.044), IL-1β (F(1,88)=4.93, p=0.029), IL-10 (F(1,88)=3.87, p=0.05), MIP-1α 
(F(1,88)=8.33, p=0.004) and MIP-2α (F(1,88)=7.34, p=0.008). 
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Table 4: Chemokines and cytokines in CD11b+ cells isolated from the parietal 
cortex altered by treatment with LPS with no effect of housing condition. All p-
values<0.05. Values based on means ± SEMs for 12 rats/group. 
Protein HC-Media HC-LPS EE-Media EE-LPS 
Main Effect 
of LPS 
IL-1α 7.0±1.5 47.1±8.8 5.9±0.8 41.5±9.5 
F1,44=33.2, 
p<0.001 
MIP-1α 154.2±16.1 394.1±44.8 169.8±17.4 421.4±51.6 
F1,44=46.2, 
p<0.001 
MIP-2α 346.7±41.7 1591.5±132.9 302.9±29.0 1552.2±161.4 
F1,44=134.3, 
p<0.001 
TNFα 3.1±0.5 44.6±5.6 2.8±0.4 48.6±5.8 
F1,44=115.8, 
p<0.001 
 
5.3.4. The CD11b/c-negative population does not differ in mRNA 
expression of signaling molecules that interact with microglia 
The CD11b/c-negative population was analyzed for mRNA expression of genes 
related to neuronal interaction with microglia. As noted previously (Chapters 2 & 4), 
neurons can make direct contact with microglia with their surface-expressed and 
secreted products (234, 235). In the CD11b/c-negative population from the hippocampus, 
neither CX3CL1 mRNA expression (Figure 26a; t(22) = -0.33, p=0.74) nor CD200 mRNA 
expression (Figure 26b; t(22) = 0.48, p=0.64) is different between the two housing groups.  
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Figure 28: Neuronal molecules that interact directly with microglia are not 
different between housing conditions in the hippocampal CD11b/c-negative 
population. a) Fractalkine (CX3CL1) is similarly expressed at the mRNA level in 
CD11b/c-negative cells. b) CD200 mRNA expression is similar in both housing groups 
in the CD11b/c-negative population. 
These results replicate the lack of difference between housing groups seen in the 
previous EE experiment (Chapter 4), indicating that neural signals to microglia are not 
changed by EE, but rather microglial sensitivity to neural modulation is likely 
augmented following EE (i.e., increased CD200R expression).  
5.4. Discussion 
We have demonstrated that environmental enrichment has a marked effect on 
glial antigen expression in the DG, increasing GFAP expression and Iba1 expression, 
though the latter was significantly increased by peripheral immune challenge as well. In 
this study, we have shown that the number of GFAP+ cells is not altered in the DG of EE 
rats compared to HC controls. The estimated hippocampal volume represented in these 
counts is not different between the two groups; therefore, we can conclude that the 
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number of cells per cubic micron (μm3) is similar within the DG of both housing groups. 
Iba1 counts showed a similar pattern of results, such that the number of Iba1+ cells was 
not altered in the DG of EE rats compared to controls and the estimated hippocampal 
volumes were similar between housing conditions. However, the average Iba1+ cell 
volume was significantly reduced in EE rats, indicating a baseline reduction in soma size 
as a result of EE.  This change in cell volume may be correlated to the attenuated 
cytokine and chemokine response we observed in the first enrichment study, such that 
smaller quiescent microglia respond less strongly to peripheral infection. Recent 
evidence indicates that ASC, a protein commonly associated with inflammasome 
complexes may also have an important role in cytoskeleton reorganization (315). 
Inflammasomes are intracellular protein complexes that assemble in response to a 
pathogenic signal and are key regulators of the innate immune response. ASC protein 
may be part of the mechanism linking the smaller cell size to reduced reactivity to 
peripheral challenge. Furthermore, the increased CD200R expression in EE rats from our 
previous enrichment study may be the cause of decreased microglial soma size by 
increasing microglial receptiveness to inhibitory neural signals via CD200.  
While astrocyte (GFAP+) cell number was not altered by EE, it is important to 
note that GFAP is expressed by other cell types in the brain in addition to astrocytes and 
does not label entire cells (i.e., both somas and processes) when used as an 
immunohistochemical marker. Furthermore, counting GFAP+ cells does not address 
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changes in GFAP on a per-cell basis, such that the increase in antigen density that we 
previously measured may likely stem from increased GFAP expression per cell rather 
than an increase in cell numbers.  It is possible that changes in GFAP might be evidence 
of alterations to many cell types within the DG rather than a change in astrocytes per se. 
Other methodologies, such as Western blot for GFAP or ALDH1l1 protein within the 
hippocampus, may better elucidate the changes in astrocytes that we believe are 
occurring during EE. Laser capture of the DG followed by one of those methods may be 
yet another, more accurate way to assess the effects of EE on the glia in the neurogenic 
niche. Unlike GFAP staining, the Iba1 antibody stain fills somas and processes on 
microglia. The distinction between smaller somas noted in this study and increased glial 
antigen density in the former study may be accounted for by Iba1 density on microglial 
processes, which were not analyzed here. Analyses of these Iba1+ cells likely accurately 
reflect the effects of EE at baseline prior to immune challenge.  
Rather than a peripheral in vivo challenge that we performed in our earlier study, 
we instead isolated microglia (CD11b+ cells) and treated them ex vivo with 
lipopolysaccharide to assess the effects of EE on microglia alone. The cytokine and 
chemokine response of microglia to LPS in culture is not different between housing 
groups. Both groups had robust upregulation of cytokine and chemokine secretion. 
However, the response of hippocampal microglia in culture was significantly lower than 
microglia from the adjacent parietal cortex for several cytokines and chemokines, 
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indicating that the hippocampal microglia may be slightly less reactive overall. These 
data provide evidence that the hippocampus is distinct from other cortical areas, 
regardless of the influence of EE on microglia reactivity. The remaining hippocampal 
cells (CD11- population) had similar expression of fractalkine (CX3CL1) and CD200, 
replicating the previous study and indicating that changes in microglial reactivity are 
not caused by alterations in these inhibitory proteins from neurons. 
Nevertheless, the results from the ex vivo challenge must be interpreted with 
some caution. The isolation process, though rapid, is capable of activating microglia, 
which can be seen in the detectable cytokine levels in the Media condition. The media 
used in this study also contained serum (FBS), a substance that microglia in vivo only 
encounter during grave injury or insult. While the serum in the media improved cell 
survival (data not shown), it may account for the increased baseline readings in the 
Media conditions as well as for the lack of group difference resulting from housing 
condition. Furthermore, microglia in vivo do not interact directly with LPS that is 
administered peripherally, as it does not cross the blood-brain barrier (BBB); thus, the 
response seen to LPS in culture may be a reaction that would be attenuated in vivo by the 
BBB and/or the presence of other cell types.  
Taken together, these data indicate that the effects of environmental enrichment 
on microglia require the presence of and interaction among all cell types within the 
hippocampus. Without neurons and astrocytes, microg
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reactive to an immune challenge as microglia from controls. Thus, the modulation on 
microglial reactivity is likely interactions among the cells types of the entire 
microenvironment of the DG rather than alterations driven by EE that occur in microglia 
independently of others cells. The effects we observed in our previous study may be the 
consequence of interactions between microglia and other neural cells as well as growth 
factors and other changes in signaling that result from EE. Notably, hippocampal 
microglia are still distinct from adjacent cortical microglia, even when stimulated ex vivo, 
indicating a baseline regional difference that may be augmented by EE’s effects on the 
hippocampus. The specific effects on astrocytes during EE remain to be fully explored, 
either using improved counting methods or other protein analyses. The profound effects 
of EE on glia and immune signaling with the hippocampus are just beginning to be 
explored and these data provide a greater understanding of the influence of enrichment 
on glial phenotype. 
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6. Summary and Conclusions 
Animals rely on their hippocampus for encoding memories and navigating 
throughout their environments. The hippocampus itself is a unique cortical structure 
that is dynamic and plastic. It is one of only two regions known to continue producing 
and integrating new cells into its network through neurogenesis and is well-
characterized as a region capable of molecular, cellular and network alterations that 
directly affect learning and memory. In addition to its flexibility, the hippocampus is 
vulnerable to disruptions both inside and outside of the CNS.  The juxtaposition of these 
two traits – vulnerability and plasticity – may have similar underlying mechanisms. As 
recent research has shown, signaling by immune molecules and microglia modulate 
both hippocampal plasticity and vulnerability, and conversely, changes in hippocampal 
plasticity may alter immune signaling within the CNS.  
The first goal of this dissertation research was to assess the roles of microglia and 
immune signaling molecules within the CNS in a model of hippocampal vulnerability. 
Neonatal infection occurs during the critical period of early postnatal brain development 
and microglial proliferation in the CNS. Chapter 2 (Experiment 1) sought to define the 
molecular mechanism and cellular source of the fear conditioning memory impairment 
that occurs as a consequence of early-life infection. The results indicate that neonatally 
infected rats given LPS as adults (“two-hit” rats) have exaggerated interleukin-1β 
expression within the hippocampus during learning. These data demonstrate that 
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microglia (CD11b+ cells) are the primary source of that exaggerated IL-1β. Isolated 
microglia from neonatally infected rats are more reactive at baseline and following ex 
vivo stimulation with LPS. Furthermore, blocking glial reactivity with minocycline, 
either following LPS injection or following learning, eliminates the learning impairment 
in “two-hit” rats. The impairment requires “unmasking” by the second immune 
challenge in adulthood; however, this experiment showed that microglia in neonatally-
infected rats are more reactive to external challenges and to learning events. 
The second goal of this dissertation research, in Chapter 3 (Experiment 2), was to 
further elucidate the effects of neonatal infection on hippocampal-dependent learning 
and to determine if neural activation within the hippocampus is affected by neonatal E. 
coli infection during learning. Acquisition of a platform location during a Morris Water 
Maze task was not affected by neonatal infection during minimal or extensive training. 
Neonatal infection did, however, lend an advantage during memory testing after 
minimal training, such that neonatally infected rats had better memory for the platform 
location 48HR later. Interestingly, this advantage disappeared after reversal training and 
neonatally infected rats were significantly impaired in their memory for the reversal 
platform. Thus, the greater precision after minimal training may be coupled to a lack of 
flexibility, such that a better memory for one location (i.e., the original platform) may 
interfere in the formation of the memory for another location (i.e., the reversal platform).  
The improved memory following minimal training was correlated with decreased Arc 
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protein expression within the dentate gyrus of the hippocampus. The reduction in Arc 
protein in the DG may be evidence of smaller neuronal network activation by the 
learned location and a possible correlation of that network to improved memory. During 
the reversal memory test, there were no differences in Arc protein expression in the DG 
between controls and neonatally infected rats, indicating that the hippocampus may not 
be the neural substrate most important for behavioral reversal. Indeed, the prefrontal 
cortex has been implicated in several types of reversal learning (274-277) and requires 
further study.  
The results from the model of neonatal infection and its resulting hippocampal 
vulnerability led to the third goal of this dissertation research, which was to test the 
hypothesis that environmental enrichment, a manipulation known to increase 
hippocampal plasticity in several ways, can reduce or eliminate the vulnerability of the 
hippocampus to an immune challenge. In Chapter 4 (Experiment 3), the results indicate 
that environmental enrichment has a dramatic effect on glial antigen expression (i.e., 
GFAP on astrocytes and Iba1 on microglia) and that EE significantly attenuates the pro-
inflammatory response within the hippocampus to an LPS challenge. In response to the 
immune challenge, environmentally enriched rats had lower mRNA expression of IL-1β, 
TNFα and members of its signaling family, and several chemokines within the 
hippocampus, and notably, the response in the adjacent parietal cortex was not different 
between housing groups to LPS. Alterations in gene transcription were specific to the 
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hippocampus, and changes to glial antigen expression were confined to the neurogenic 
niche of the DG within the hippocampus. Further work with environmental enrichment 
(Chapter 5; Experiment 4) assessed the specific effects of EE on microglial reactivity as 
well as specific changes in glial cell number or morphology that contributed to increased 
glial antigen density measurements in Chapter 4. The results show that numbers of 
astrocytes and microglia are not altered within the DG, but microglia volume is reduced 
in response to EE. The reduction in microglia volume at baseline may correlate with the 
attenuated pro-inflammatory response seen following an in vivo immune challenge. 
However, isolated microglia that are stimulated ex vivo have the same robust response to 
LPS, regardless of housing condition. Hippocampal microglia, however, have a lower 
response to LPS than microglia isolated from the parietal cortex, indicating a possible 
baseline difference in microglial reactivity between these two regions. Notably, the 
microglial phenotype we observed ex vivo following enrichment does not replicate the 
reactivity observed in vivo after EE and an immune challenge. In the neonatal infection 
model, the ex vivo phenotype mirrored the in vivo phenotype with greater microglial 
reactivity observed in both experiments. Neonatal programming by infection during a 
critical period of brain and microglial development has a profound and enduring effect 
on hippocampal microglia phenotype, even in isolation from other cells, while 
enrichment has a robust effect on in vivo responses only. The manipulation of 
enrichment during adulthood may contribute to its potentially transient effects on the 
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inflammatory response within the hippocampus. Neonatal infection, however, can 
permanently program microglia well into adulthood and old age. These results indicate 
that it is likely the neurogenic niche of the DG and the microenvironment in which the 
microglia reside that determines their morphology and reactivity to immune challenge.  
Taken together, the experiments in this dissertation have provided evidence that 
alterations in microglia reactivity and immune signaling, especially early in life, have 
dramatic effects on hippocampal-dependent learning and memory and that changes in 
hippocampal plasticity have significant effects on microglia reactivity and immune 
signaling within that region.  The connections between these phenomena are just 
beginning to be elucidated, and these experiments provide evidence that microglia are 
critical for hippocampal function and that changes in plasticity have profound impacts 
on microglia, even in adulthood. Cytokines and chemokines are central molecules in 
hippocampal risk and resilience, and these molecules can no longer be considered solely 
immune signals, but perhaps neuromodulators as well. Specific relationships between 
cytokine signaling and neurotransmitters are as yet minimally explored and in the 
future, it will be important to consider how cytokines and chemokines influence neural 
plasticity at the network level. The broader implications of this work indicate that the 
hippocampus remains a critical neural substrate in understanding the complex 
relationships between the immune system and the CNS. Hippocampal-dependent 
neural function may be immune-dependent as well, and neuromodulation by immune 
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molecules may occur primarily in the hippocampus as a response to the region’s 
remarkable plasticity.   
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